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Incidence of preterm birth
 The incidence of preterm birth is increasing in The Netherlands as well as in the 
United States. In 2004, 12.5% of all live births in the United States was a preterm 
birth, which is an increase of 18% since 1990. Although multiple births have con-
tributed to this recent rise, preterm rates for singletons have also increased, up 11% 
since 19901. The preterm birth rate continued to rise in 2005 (to 12.7% in 2005) as 
did the rate for LBW births (8.2%)2.
 In 2001 there were approximately 16,000 infants born preterm (less than 37 weeks 
pregnancy) in the Netherlands, which is 8% of all live births. There were 2,200 very 
preterm births (born less that 32 weeks pregnancy). The incidence of very preterm 
births has increased between 1983 and 1999 from 1,068 to 2,170 infants, which is a 
relative increase from 6.8 per 1000 to 10.8 per 1000 live births3. 
 As some of the risk factors for a premature birth are also increasing, i.e. older 
average age that a woman has her first child as well as a higher maternal age in 
general, infertility treatments, multiple births, better prenatal care and improved 
diagnosis and treatment, it is expected that the rise in infants born prematurely will 
continue4. 
Risks associated with prematurity
 Advanced technology in the treatment of preterm infants has resulted in decreas-
ing mortality rates. However all preterm infants are at heightened risk of morbidity 
and mortality compared with infants born at higher gestational ages2. Some of 
the complications that may occur as the result of being born preterm are respira-
tory distress syndrome (RDS), intraventricular hemorrhage (IVH), periventricular 
leukomalacia (PVL), patent ductus arteriousus (PDA), necrotizing enterocolitis 
(NEC), infections, bronchopulmonary dysplasia (BPD), and retinopathy of prema-
turity (ROP)5. Higher survival rates of very preterm infants have not necessarily led 
to lower morbidity rates, and has been associated with a higher incidence of intra-
ventricular hemorrhage and BPD6-8.  
Follow-up outcomes of preterm infants
 Follow-up studies show that preterm infants have an increased risk of devel-
opmental disorders6,9-11. Neuromotor abnormalities are the most frequent of the 
“hidden disabilities” among ex-preterm children and are frequently associated with 
poorer cognitive ability and attention deficit disorder12. A meta-analysis showed 
Chapter 1
12
increased risk of cognitive deficits and behavioral problems in preterm infants, with 
cognitive deficits greater and in direct proportion to the infant’s gestational age and 
birthweight13. Studies report a higher risk of later disabilities or handicaps at school 
age as well as learning and behavioral disorders in preterm infants 14,15. In addition, 
VLBW children have an increased risk of developing attention deficit hyperactivity 
disorders (ADHD), have generalized anxiety and more symptoms of depression16. 
The NICU environment
 Research on the sensory development of the preterm infant have shown that 
many of the environmental factors and care practices in the NICU have a significant 
impact on infant sensory development. In addition, problems of sleep deprivation 
are related to care practices and NICU organization17,18. Current evidence suggests 
that the NICU environment has strong influences on physiological functioning 
(hypoxemia, apneas, etc.) and in turn influences the long-term development of the 
weak and vulnerable central nervous system19,20. Because premature infants cannot 
regulate incoming stimuli, they become easily overstimulated and stressed. Als 
and colleagues propose that there is a sensory mismatch of the premature infant’s 
developing nervous system’s expectations for environmental inputs and the actual 
sensory overload that is experienced in the neonatal intensive care. This in turn can 
lead to a greater chance for later developmental problems21,22. 
Parents of premature infants
 In addition, many factors in the NICU environment may adversely affect parent-
infant attachment and parent involvement essential for long-term development23. 
Family bonding in the NICU is often a very difficult process, due to the separation 
of parents and child at birth and the continued physical restraints of the complex 
critical care environment. Cronin et al report that parents of very low birth weight 
infants (< 1500 grams) continue to manifest stress even up to 5 years after the birth 
of the child24. Involving parents in the care of their infant and instructing them in 
premature behavior may facilitate bonding, increase parents’ confidence in care-
giving and possibly decrease the chance of later disturbances in the parent-child 
relationship.
 The nature of the relationships that families develop with health care providers in 
the NICU may have a profound influence on how individuals and families respond 
to the experience of having a preterm infant25. 
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Developmental Care
 The challenge confronting healthcare professionals who care for preterm infants 
and their families is not only to assure the infants’ survival, but to optimize their 
developmental course and outcome26. 
 In order to address these problems, researchers have concentrated on ways to 
improve the care and environment of the NICU for infants and parents through the 
use of developmental care programs. In the last 15-20 years, interest has increased 
and programs have been implemented in various neonatal nurseries. The philosophy 
behind developmental care is to reduce stress and support development of premature 
infants as well as their parents. The NIDCAP (Newborn Individualized Developmen-
tal Care and Assessment Program) is a comprehensive program used as a framework 
for the implementation of individualized developmental care in the NICU26. 
NIDCAP
 The NIDCAP program is an approach in which the infant’s behavior provides 
the best information from which to design care27. Repeated, systematic behavioral 
observations of the infant are carried out and recommendations for caregiving are 
made based on these observations. These behavioral observations are based on the 
Synactive Theory of Development which states that there is a continuous interaction 
of five subsystems within the developing infant: the autonomic system, the motor 
system, the state organizational system, the attentional-interactive system, and the 
self-regulatory system 27,28. The infant is in constant interaction with the environ-
ment and the infant’s level of functioning can be observed via these subsystems. 
 The autonomic system’s functioning is observable in the infant’s breathing 
patterns, color fluctuations and visceral stability or instability such as bowel move-
ments, gagging and hiccoughing. The motor system functioning is observable in 
the infant’s body tone, postural repertoire and movement patterns, as reflected 
in facial and trunkal tone, tone of the extremities and in the extensor and flexor 
postures and movements of face, trunk and limbs. State organization is observable 
in the infant’s range of available states (from sleeping, to alert, to aroused), their 
robustness and modulation and the patterns of transitions from state to state. 
Some infants show the full continuum of states, from deep sleep to light sleep, then 
to drowsy and quiet alert and to active awake and aroused and then to upset and 
crying29. Other infants during interactions move from sleep to aroused states and 
immediately back to sleep again, skipping the alert state. Thus state stability and the 
smooth transition from state to state would reflect intact state organization whereas 
the opposite would reflect disorganization21. The attention and interaction system is 
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seen in the infant’s ability to come to an alert, attentive state and to use this state to 
take in information from the environment and in turn, elicit and modify these inputs 
from the world around him. The self-regulatory system is seen in the strategies the 
infant uses to maintain a balanced, relatively stable state of subsystem integration 
or to return to a more balanced and relaxed state28 (Table 1). 
 The five subsystems are interdependent and interrelated. For example, physi-
ological stability lays the foundation for motor and state system control. State 
organization, the management of sleep–wake cycles, creates a component of self-
regulatory competence. The loss of integrity in one system influences the other 
systems, as they manage environmental demands 30. 
 The behavior of the infant and how the infant is coping with the environmental 
inputs can be observed via the subsystems and the balance of avoidance, stress 
behaviors and approaching, self-regulatory behaviors21,27. The infant uses these 
strategies and mechanisms to move away from and avoid inappropriate envi-
ronmental demands or to seek out and move towards inputs currently appropri-
Table 1. Behavioral systems and channels of communication
Subsystems Channels of communication
Autonomic/physiologic - respiration pattern
- color changes
- heart rate
- visceral stability
Motor - posture 
- tone
- movements
State29
 - Deep sleep
 - Light sleep
 - Drowsy
 - Quiet alert
 - Active awake, aroused
 - Upset, crying
- range of states
- state transition patterns
- robustness of states
Attention-Interaction - ability of the infant to come to an alert, attentive state, take in 
  input and interact with the environment
Self-regulatory - strategies used to return to a calm balanced state 
- behaviors the infant uses to bring and keep the subsystems 
  in balance
Based on the Synactive Theory of Development from Als27
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ate for the infant’s intake capacities. Avoidance behaviors are believed to reflect 
stress. Approach and self-regulatory behaviors are seen when the input does not 
exceed the capabilities of the infant. For example, extension behaviors primarily are 
thought to reflect stress and disorganization and flexion behaviors are thought to 
reflect self-regulatory competence. Diffuse behaviors are thought to reflect stress 
and well-defined robust behaviors reflect self-regulatory balance 21. 
 
 This model is based on the assumption that the infant actively and consistently, 
through his behavior, communicates his/her thresholds for sensitivity versus com-
petence. The range of infant behaviors becomes evident as the infant matures30.
 If the input is too much for the infant and his own regulatory capacities are 
exceeded, a further parameter of functioning is seen in the kind and amount of 
facilitation that is needed to help the infant return to a more balanced subsystem 
functioning28. Sensitivity to these signs of organization or disorganization provides 
the caregiver with an understanding of each infant’s threshold for activity and stim-
ulation30.
 In the healthy full term newborn the five subsystems are mature, integrated, syn-
chronized and managed smoothly. All five systems are managed easily and without 
stress. The less mature, healthy preterm or sick preterm may be unable or partially 
able to manage environmental inputs, demonstrating over-reactive responses and 
poor tolerance from even minimal input. Loss of control and stress responses 
become frequent unless the environment and caregivers work to read the infant’s 
messages and thresholds for sensitivity and adjust care and handling and the envi-
ronment based on the infant’s behavioral communications30.
 A behavioral observation method is used based on the assumption that the 
behavior of the infant is the primary route for communicating thresholds to stress 
or relative functional stability. The observation is carried out for 20 minutes before 
caregiving or handling in order to have a baseline of the infant’s behavior, during 
the caregiving and for at least 10 minutes after caregiving in order to assess the 
infant’s ability to recover and what interventions may be needed to help facilitate 
the infant. The observation sheet is divided into 2-minute time segments in which 
specific behaviors observed can be checked. A narrative descriptive of the infant’s 
behavior before, during and after caregiving is made based on the observation, with 
interpretation of behavioral signals as stress vs. self-regulatory behaviors. On the 
basis of this description, an individualized developmental care plan is made with 
suggestions for the reduction of stress behaviors and the increase of self-regula-
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tory behaviors. These may include interventions in the physical environment of 
the infant, direct caregiving and discharge planning28. The emphasis of NIDCAP 
is on an individual approach in which the behavior of the infant is used to deliver 
caregiving.
Various components of a developmental care program may consist of: 
a) Reducing environmental sources of stress by lowering noise, light and activity 
levels and the use of incubator covers. Nurseries should be quiet, soothing 
places with individual dimmed lighting.
b) Supporting motor development by positioning the infant in comfortable aligned, 
softly flexed positions during sleep and caregiving interaction and using various 
materials and buntings to provide soft boundaries. 
c) Providing containment by gently swaddling the infant’s body, arms and legs 
with your hands or with a soft blanket to reduce diffuse and jerky movements 
during caregiving interactions.
d) Reducing the physiological and behavioral destabilization associated with pro-
cedural handling by providing support or containment, allowing the infant a 
“time-out” when thresholds to stress are exceeded, and providing aids for self-
regulation, such as pacifiers or objects to grasp.
e) Supporting organization of sleep-wake states through preserving undisturbed 
rest periods and providing light-dark cues for the development of circadian 
rhythms.
f) Attention to readiness for and the ability to take oral feedings, providing indi-
vidual feeding support determined by the infant’s individual needs and prefer-
ences. Feeding success is not only judged by the infant’s intake but also by the 
infant’s overall energy levels and autonomic, motor and state functioning. 
g) Involving parents in the care of their infant and guiding parents in recognizing 
their infants behaviors and ways in which they can support their infant during 
caregiving interactions 21,31,32.
Developmental care studies carried out up to 2000
 Studies evaluating the effect of individual developmental care were published 
from the mid 1980’s. The first study published was a phase-lag study, after that 
various RCT’s were carried out31,33-37. Many of the developmental care studies 
originate from the United States and Sweden where most infants remained in the 
same neonatal unit until discharged to home (Table 2).
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Developmental Care in NICU’s in the Netherlands 
 Developmental care programs were relatively unknown in the Netherlands in 
1999.  Since then, the interest for developmental care and NIDCAP has increased. 
Studies that have been published to date are scarce. Before NICU’s in the Nether-
lands implement developmental care programs, research is needed to evaluate the 
effectiveness of this program in our present neonatal system. 
 One of the criticisms of developmental care programs has been that it is 
difficult to ascertain which of the components are responsible for the improved 
outcomes36,38-40. It was suggested that research is needed in which the effectiveness 
of the various components of the developmental care program can be evaluated in 
addition to the comprehensive NIDCAP program.
 In this thesis we have attempted to answer some of these questions as well as 
measure the effect of developmental care in a NICU in the Netherlands. The study 
consisted of a pilot study measuring the effect of a short-term, hospital based inter-
vention with parents in which they were instructed in preterm infant behavior with 
the goal of increasing their responsiveness to their infant and therefore their confi-
dence in caregiving. This was followed by two consecutive randomized controlled 
trials.
 The phase one RCT evaluated the effect of basic elements of developmental care 
(standardized incubator covers and nests and positioning aids) designed to reduce 
stress and improve physiological stability in infants compared to standard care, 
which at that time consisted of no covers or nesting. 
 The phase two RCT studied the effect of the comprehensive NIDCAP (Newborn 
Individualized Developmental Care and Assessment Program), with the use of the 
behavioral observation and assessment tool with recommendations for caregiving 
as well as supporting the parents, as compared to the basic elements of develop-
mental care. 
Outline of this thesis
 This thesis examines the effect of a developmental care program in a tertiary 
NICU at two locations in the Netherlands on preterm infants born < 32 weeks ges-
tational age. 
 Chapter 2 describes a pilot study to evaluate the effect of a short-term, hospital 
based intervention with parents and their premature infants born < 32 weeks ges-
tational age in the neonatal department of the Leiden University Medical Center, in 
which parents were instructed in understanding preterm infant behavioral cues. 
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 In Chapter 3 we examine the effects of basic developmental care on short-term 
morbidity, growth and neurodevelopmental outcomes to term age.
 Chapter 4 studies the effect of basic developmental care on 1 and 2 year growth 
and neurodevelopmental outcomes.
 Chapter 5 describes the effect of the comprehensive NIDCAP developmental 
care program on short-term morbidity, growth and neurodevelopmental outcomes 
to term age.
 Chapter 6 examines the effect of NIDCAP on 1 and 2 year growth and neurode-
velopmental outcomes.
 Chapter 7 contains the General Discussion on the results of this study.
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Abstract
The effect of a short-term intervention with parents in the Neonatal Intensive 
Care Unit (NICU) on their knowledge of infant behavioral cues and confidence 
in caregiving was examined. Ten sets of parents with a total of 22 premature 
infants born < 32 weeks gestational age admitted to a NICU were enrolled in a 
time-lag control trial over an 8 month period. The intervention group was given 
4 sessions of instructions on preterm infant behavior for a period of 2 weeks. 
The control group did not receive the instructions. All parents completed two 
subscales of the Mother and Baby Scale (MABS) at weeks 1 and 3 and a short 
questionnaire concerning nursing support at week 3. Intervention parents 
completed a pre-and post-test on knowledge of preterm infant behavioral cues 
at weeks 1 and 3. There was a significant improvement in the post-test scores 
concerning knowledge of preterm infant behavioral cues and a higher nursing 
support score for mothers in the intervention group. Intervention mothers 
showed no significant improvement in confidence in caregiving. Only half of 
the intervention group fathers participated in the sessions and there were no 
significant differences in fathers’ scores. While the intervention significantly 
increased maternal knowledge of infant behavioral cues, there was no signifi-
cant effect on mothers’ confidence in caregiving. Very few fathers participated in 
the entire intervention. A longer, more intensive program with a larger sample 
size and finding ways of incorporating more participation from fathers is rec-
ommended. 
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Introduction
 The advances in recent years in neonatology have resulted in a marked improve-
ment in the mortality of premature infants 1-3. As more infants are surviving, the 
importance of finding ways to improve developmental outcomes and their quality 
of life becomes paramount. In addition to the increasing concern with the devel-
opmental support of the infant, there has been a heightened appreciation of the 
psychological strain and emotional stresses encountered by the family of the sick 
neonate 4. 
 In addition, many factors in the neonatal intensive care unit (NICU) environment 
may adversely affect parent-infant attachment and parent involvement essential 
for long-term development 5. Family bonding in the NICU is often a very difficult 
process, due to the separation of parents and child at birth, uncertainty about their 
child’s wellbeing and the continued physical restraints of the complex critical care 
environment. Cronin et al reported that parents of very low birth weight infants 
continue to manifest stress even up to 5 years after the birth of the child 6. In 
addition, because of their poor motor stability and difficulty maintaining alertness, 
premature infants do not engage in the social interactions typical of term infants. 
Preterm infants’ cues and interaction signals are often weak and disorganized and 
too often missed 7. This in turn may make it more difficult for the parents to form a 
relationship with their infant. 
 Involving parents in the care of their infant and instructing them in premature 
behavior may facilitate bonding, increase parents’ confidence in caregiving and 
possibly decrease the chance of later disturbances in the parent-child relationship 
6. Supporting parents to understand their infant’s level of communication through 
his/her behavior may help them feel more comfortable with their baby and may 
promote bonding between parents and child. 
 Various interventions aimed at improving the contact between parents and their 
infant have been carried out, with some showing promising results 8-11. The studies 
differed in type and length of intervention as well as study design. Some studies 
were only carried out with participation from the mothers and continued over a 
longer period of time with home-based follow-up instructions. A shorter hospital-
based intervention may be more relevant to the Dutch situation where infants may 
be transferred to regional hospitals once they are stabilized. 
 The present study examined the effects of a short-term, hospital based inter-
vention with parents and their premature infants in the neonatal department of a 
tertiary Dutch university hospital. The intervention program was based on aspects 
of developmental supportive care with the goal of positively influencing parental 
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knowledge and responsiveness to premature infant signals and behavioral cues. It 
was based on the assumption that once parents understand their infant’s behavior, 
they will be in a better position to respond to and interact with their infant in an 
appropriate and developmentally supportive way and therefore be more confident 
and comfortable in their interaction with their infants.
Methods
Design
 The study took place in a 17 - bed level III NICU and was a time-lag design. 
The study was approved by the review board and medical ethics committee of 
the hospital and written informed consent was obtained from parents. Inclusion 
criteria were: birth of a preterm infant < 32 weeks with no congenital malformation 
and requiring no major surgery. The duration of the study was 8 months. 
 Control group parents were first recruited consecutively over a 4-month period. 
Parents in the control group received the standard support normally given by the 
nurses. After questionnaires and data were collected from the control group, the 
recruitment of the intervention group of parents began and was carried out over a 
4-month period. 
Intervention
 The researcher met with the parents in the intervention group four times over a 
two-week period during the infants’ second and third week of life and the sessions 
lasted between 20 and 30 minutes. The teaching sessions were interactive in nature 
and were primarily carried out with parents and infant individually at the infant’s 
bedside. Material with photos was used for explaining infant behavior and how to 
read premature infant’s cues 7,10,12-14. The goal was to support parents in becoming 
more knowledgeable in preterm behavior in order to better understand their own 
infant’s behavior. Care was taken to present the information in an interactive 
manner that was easily understandable and supportive of the parents own observa-
tions of their child. 
Measures
 Demographic variables collected were parental age, educational level and country 
of birth (Netherlands/other). Infant characteristics at birth were the infant’s gender, 
gestational age, birth weight, Apgar score at 5 minutes and twin (yes/no).
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Neonatal behavior and parental confidence
 Two subscales of the MABS (Mother and Baby Scales) were given to parents to 
complete. The MABS is a parent-report measure of neonatal behavior and parental 
caretaking confidence 15. The subscale “Lack of Confidence in Caregiving” (LCC) 
assesses parental perception of their own caregiving confidence, contains 13 items 
and has a reliability of 0.93 as measured by Cronbach’s alpha. The subscale “Global 
Confidence” (GC) is a short impressions measure from the overall impressions 
and experiences section, contains 3 items and has a reliability of 0.81. A higher 
score of the LCC scales indicates an increase in the lack of confidence in caregiv-
ing, whereas a higher score in the GC scales indicates a higher overall global con-
fidence. The subscales of the MABS were translated from English into Dutch and 
two of the questions in the subscale “lack of confidence in caregiving” were altered 
slightly so that they would be more appropriate for the situation in the neonatal 
intensive care unit. Cronbach’s alpha was then computed for each subscale. Alpha 
was reasonable to good. 
Knowledge of premature infant behavior
 In addition, parents of the intervention group were given a pre- and post-test 
on premature infant behavior developed specifically for this study, based on the 
material that would be presented in the instructions started when their infants were 
1 and 3 weeks old. The questionnaire measures knowledge of infant behavior. Total 
possible score was 30. A high score indicated increased knowledge. 
Parents’ experience of nursing support in the NICU     
 Parents from both groups were asked at the end of week 3 to complete a short 
questionnaire concerning their experience in the neonatal intensive care unit. Four 
of the items were found via reliability analysis to form a scale concerning nursing 
support given to the parents in those first three weeks (Cronbach’s alpha = .81). 
The items were:
1. How did you find the support from the nursing staff the first week?
2. How was it the weeks thereafter?
3. Do you feel that you received sufficient information about your baby?
4. Do you feel that the nursing staff involved you enough in the caring for your 
baby?
Chapter 2
28
Need for more knowledge
 An open-ended question was asked at post-test if parents felt the need for more 
knowledge concerning premature infant behavior (yes or no).
Procedure
 Parents in the control group and intervention group completed subscales from 
the Mother and Baby Scale (MABS) questionnaire when their infant was one week 
old and again two weeks later. The intervention group was given 4 sessions of 
instructions in preterm infant behavior for a period of 2 weeks. The control group 
did not receive the instructions. All parents received along with the 2 modified 
subscales of the Mother and Baby scale (MABS) at weeks 1 and 3 a short question-
naire concerning nursing support at week 3. In addition the intervention group 
completed a pre- and post-test on knowledge of preterm infant behavioral cues at 
weeks 1 and 3. At the end of the 3 weeks parents were interviewed concerning their 
experience in the NICU.
Statistics
 Data was analyzed using SPSS 11 for Windows (SPSS Inc., Chicago, Illinois, 
USA). Demographic variables and questions concerning parents’ experience in the 
neonatal department were compared between groups using Pearson’s chi-square 
and t-tests. Differences between groups for the MABS scores were compared using 
independent group t-tests and differences between pre- and post-tests within each 
group were compared using the paired sample t-tests. 
Results
Participants
 Twenty-eight preterm infants of 13 sets of parents admitted to the neonatol-
ogy department were enrolled after meeting the inclusion criteria. Three couples 
dropped out, one because their infant died after one week and two because their 
child was transferred to another hospital. There were five sets of twins; in two 
sets, one of the twins died and in one set, one twin had anomalies, so these three 
children were also excluded from the study. In addition the control group and inter-
vention group each had one set of living healthy twins. In total 3 infants died, 2 
were transferred and one was born with anomalies, leaving 22 infants with 10 sets 
of parents in the sample. 
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Intervention and Control Variables
 There were no significant differences in age, educational level or country of birth 
between mothers and fathers in the control and intervention groups (Table 1). No 
parents from either group had ever had a premature infant before. There were no 
significant differences in gender, gestational age at birth, birth weight or Apgar score 
at 5 minutes between infants in the control and intervention groups (Table 2). 
Table 1. Comparison of parent characteristics 
Control
(n-=10)
Intervention
(n=10)
p value
Maternal age at infant’s birth
< 30 years 8 6 0.33
≥ 30 years 2 4
Paternal age at infant’s birth
< 30 years 3 2 0.61
≥ 30 years 7 8
Maternal education level 
(low/intermediate/high)* 
4/5/1 1/9/0 0.14
Paternal education level 
(low/intermediate/high)*
9/1 9/1 1.00
Country of birth mother
(Netherlands/other)
9/2 9/2 1.00
Country of birth father
(Netherlands/other)
9/1 8/2 0.53
Comparisons were done using chi-square; p value significance = <.05
* Low = vocational training, intermediate = high school, high = college/university
Table 2. Comparison of infant characteristics
Control 
(n-=11)
Mean (sd)
Intervention
(n=11)
Mean (sd)
p value
Gender (female/male) 5/6 6/5 0.67
Gestational age at birth (weeks) 29.0 (1.8) 28.5 (1.2) 0.47
Birth weight (grams) 1075.1 (208.7) 1215.4 (402.8) 0.32
Apgar score at 5 minutes 7.8 (1.3) 7.6 (1.9) 0.79
One of a twin (no/yes) 6/5 8/3 0.38
Comparisons were done using t-test or chi-square test as appropriate.
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Outcome variables
Knowledge of preterm infant behavior
 There was a significant improvement in the post-test scores concerning knowledge 
of preterm infant behavioral cues for mothers who underwent the training (pre-test 
score 15.5; post-test score 24.1 from a possible total score of 30, p= < 0.001). Since 
only 5 fathers in the intervention group participated in the teaching sessions and 2 
of them did not complete the post-test on infant behavior they were not included 
in this analysis.
Confidence in caregiving (CCG) and global confidence (GC)
 There was no significant difference in the baseline MABS scores of the control 
group and intervention group of mothers and fathers, indicating that both groups 
had comparable initial levels of confidence in caregiving at the start of the study 
(mothers: mean CCG score: C=20.9, I = 18.3, p=0.54; mean GC score: C=9.6, I =9.6, 
p=0.95; fathers: mean CCG score: C=16.7, I = 18.6, p=0.64; mean GC score: C=10.7, 
I = 11.1, p=0.76).
 Scores were analyzed separately for mothers and fathers, since only 5 fathers in 
the intervention group actually participated completely in the training. Two fathers 
from the control group and three fathers from the intervention group did not 
complete all of the questionnaires. 
 The difference between the MABS scores pre- and post-test was calculated for 
each person and the mean difference scores of both groups were then compared. A 
negative mean score showed an improvement in confidence in caregiving, whereas 
a positive mean score showed a decrease in confidence in caregiving. There was 
no significant difference in the scores between mothers, although the interven-
tion group mothers showed more improvement. When comparing the fathers, we 
found no significant differences in the mean scores; however the scores of the 
intervention fathers showed an improved confidence in caregiving, while the scores 
of the control fathers showed a decreased confidence in caregiving. There was no 
significant difference in the mean difference in global confidence between mothers 
or fathers (Table 3).
Experience of nursing support in the NICU     
 The mothers in the intervention group showed a significantly higher support 
score than the control group, meaning that they felt they received more support 
from the nursing staff. There was however no significant difference in the fathers’ 
scores (Table 4).
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 In total 14 of the control group parents felt the need for more knowledge as 
opposed to only 8 parents in the intervention group, which is a significant differ-
ence (p = .022). When the data was tested to see if there was a difference between 
the fathers and mothers, a higher number of mothers and fathers in the control 
group wanted more information; however the differences were not significant. 
Table 3. Mean score differences in pre- and posttest MABS
Variables Group N Mean Std. Dev. p value
Mean score differences 
confidence in caregiving
mothers*
control
intervention
11
11
- 0.82
- 2.27
10.59
9.53
0.74
Mean score differences 
global confidence 
mothers 
control
intervention
11
11
 1.91
 0.36
2.39
2.42
0.15
Mean score differences 
confidence in caregiving 
fathers*
control
intervention
9
8
 3.33
- 3.50
8.4
8.6
0.12
Mean score differences 
global confidence fathers
control
intervention
9
8
 0.22
 1.38
1.9
1.8
0.23
Paired samples t-test; p value significance = <.05 
*Negative score indicates improvement
Table 4. Parents’ experience of nursing support in the NICU
Variables Group N Mean Std. Dev. p value
Support parents*
control 17 16.88 2.2 .049*
intervention 17 18.29 1.8
Support/mothers*
control 10 16.10 2.3 .017*
intervention 10 18.40 1.6
Support/fathers*
control 7 18.00 1.7 ns
intervention 7 18.14 2.1
Independent samples t-test; * p value significance = < .05 
*Higher score indicates more support.
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Discussion
 The goal of this study was to investigate if a short-term intervention explaining 
infant behavioral cues with parents would increase parental knowledge of premature 
infant behavior and enhance parents’ confidence in caregiving in interacting with 
their infant. The significant improvement in the parental knowledge of premature 
infant behavior suggests that the training was in itself effective. Also the fact that 
14 of the control parents felt the need for more knowledge concerning premature 
infants as opposed to only 8 parents in the intervention group suggests that the 
training fulfilled a need that parents have during this period. 
 In addition, parents in the intervention group did feel that they had received more 
support. However, their feelings of confidence in caregiving did not improve sig-
nificantly. The evaluation of the training during the interviews showed that parents 
enjoyed the instructions, felt it had been helpful in their interactions with their 
premature infant and recommended it be offered to all parents. 
 An issue to consider is whether the revised version of the MABS subscales is 
an appropriate tool sensitive enough to measure parents’ feelings of confidence 
in dealing with their infants in the intensive care unit. This scale was originally 
developed for interventions with mothers of newborns and was used for the first 
time with parents of premature infants. The global confidence scores were reason-
ably high in the pre-test which made it difficult to show a difference after an inter-
vention. Only more studies with larger samples using this instrument will tell us if it 
is an appropriate one. Since this study had a small sample size and large standard 
deviations in the scores, replication with a larger sample could give more insight in 
the effects of the intervention and for whom the intervention is most beneficial.
 Finally, while fathers initially expressed interest in the intervention, less than half 
of them actually participated in the teaching sessions. As fathers in general are 
becoming more involved in the caregiving of their children it is important to find 
ways to include them in the care of their premature infants as well. This could in 
turn help support mothers through having their partner also understand the ways 
in which their infant may respond to interactions. Further studies are needed to 
find a way to incorporate more fathers, perhaps with less individual instruction and 
more written information that could be read at their leisure. Fathers often returned 
to work and did not visit as frequently as mothers and when they did come to 
the unit wanted to spend that time alone with their baby. Most of the mothers 
who received the training stated that they shared much of the information with the 
fathers; however this “transferring” of knowledge was not measurable. 
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 Recommendations for future research include a study with a larger popula-
tion, implementing the program within the first few days after the birth, creating a 
program with a longer period of instruction with follow-up if infants are transferred 
and finding ways of incorporating more participation from fathers. 
Key guidelines
 Based on the feedback from parents in the study, the following guidelines and 
recommendations have been made.
 
In order to have a developmental care program succeed, the entire team should be 
involved: 
• Educate and train the nursing and medical team in infant behavioral cues so 
that they can support the parents and infants. A formalized training program 
such as NIDCAP (Newborn Individualized Developmental Care and Assessment 
Program) can provide training and guidance in the implementation of a develop-
mental care program. 
• Continuing in-service training and lessons for nursing and medical team.
• Have trained developmental specialists on staff who can implement and maintain 
the developmental care program. Parents often commented that they appreci-
ated having someone to discuss their infant’s behavior with instead of just the 
medical aspects. 
• A developmental specialist should participate in the rounds to give feedback 
about the infant’s behavior. 
Parents felt the need for more information concerning premature infant behavior 
and how they could support their infant: 
• Try not to overwhelm parents with information, instead begin the first week 
with basic information about the program and getting to know their infant and 
gradually increase this as parents are able to incorporate it. Be sensitive to where 
parents are in the process. 
• Make booklets with photos and explanation of infant behavioral cues available for 
parents whose infant is admitted to the NICU. Create literature for parents that 
they can read at their leisure about development of premature infants from birth 
until term age. 
• Make a library for parents of existing developmental care books and books with 
information of premature infants that they can read at their leisure. 
• Make contact with mothers who are already admitted to the hospital if possible 
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to introduce the program. This gives parents time to get acquainted with the 
developmental specialist and what support is available. 
• Regular infant observations with write-ups with key recommendations at the 
bedside for team and parents.
Increase parental participation and input and offer support to the fathers as well: 
• To make the program more accessible to fathers, have developmental specialists 
available in the evening when fathers usually come to see their infant so that they 
also can be supported and included in the program. Fathers indicated that they 
would like to take part in understanding their infant’s behavior more, but could 
not take time off from work during the day to do this.
• Encourage parents to participate together in the infant’s care, for example, when 
one parent is doing caregiving, the other parent could support and comfort the 
infant. 
• Create a multidisciplinary developmental team that also includes parents of ex-
premature babies. It is important to get the input of parents because they are the 
experts and have an understanding of what parents go through. Fathers could 
also help to create a program that would be more accessible to other fathers. 
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Abstract
Objective: The goal of this study was to investigate the effect of basic elements of 
developmental care (DC, incubator covers and positioning aids) on days of respira-
tory support and intensive care, growth and neuromotor development at term age 
in infants born < 32 weeks gestation.
Methods: Infants were randomly assigned within 48 hours of birth to the devel-
opmental care group or the standard care control group (no covers or nests). The 
intervention continued until the infant either was transferred to a regional hospital 
or was discharged from the hospital. Respiratory support was defined as days 
of mechanical ventilation and/or CPAP. Intensive care was defined as requiring 
mechanical ventilation and/or CPAP and/or weight <1000 grams. Length, weight 
and head circumference were measured (bi)weekly and at term age. Neuromotor 
development was defined as definitely abnormal (presence of a neonatal neurologi-
cal syndrome, such as apathy or hyperexcitability, hypotonia or hypertonia, hypo-
reflexia or hyperreflexia, hypokinesia or hyperkinesia, or a hemi-syndrome), mildly 
abnormal (presence of only part of such a syndrome), or normal. 
Results: A total of 192 infants were included (developmental care: 98; control: 94). 
Thirteen infants (developmental care: 7; control: 6) were excluded according to 
protocol (admitted for less than or died within the first 5 days: n =12; taken out at 
parents’ request: n =1), which left a total of 179 infants who met inclusion criteria. 
In-hospital mortality was 12 (13.2%) of 91 in the developmental care group and 8 
(9.1%) of 88 in the control group. There was no significant difference in the number 
of days of respiratory support, number of intensive care days, short-term growth, or 
neuromotor developmental outcome at term age between the developmental care 
and control groups. Duration of the intervention, whether only during the intensive 
care period or until hospital discharge, had no significant effect on outcome. 
Conclusions: Providing basic developmental care in the NICU had no effect on 
short-term physical and neurological outcomes in infants who were born < 32 
weeks gestation.
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Introduction
 Advanced technology in the treatment of premature infants has resulted in 
decreasing mortality rates1,2 3. Follow-up studies, however, have shown either an 
unchanging or increased incidence of physical disabilities, developmental delays 
and learning or behavioral and/or attention deficit/hyperactivity disorders 1,2,4,5. 
Because premature infants cannot regulate incoming stimuli, they become easily 
overstimulated and stressed, which can lead to hypoxemia, apnea and variations 
in blood pressure. Als et al propose a sensory mismatch of the premature infant’s 
developing nervous system’s expectations for environmental inputs and the actual 
sensory overload that is experienced in the NICU. This in turn can lead to a greater 
chance for later developmental problems6-8. To prevent these secondary conse-
quences, several investigators have begun to focus on ways to improve the NICU 
environment for infants and parents through the use of developmental care (DC) 
programs. 
 Most research has been based on the NIDCAP (Newborn Individualized Devel-
opmental Care Program), which is a comprehensive approach in which caregiving 
is based on the individual behavior of the infant 8. A meta-analysis by Jacobs et al 
concluded that the evidence showing a positive effect from the NIDCAP program 
is inconclusive, and they recommended additional studies with a larger sample 
size, long-term follow-up and the inclusion of cost-effectiveness evaluations 9. 
A Cochrane review evaluated the effects of various elements of DC (positioning, 
clustering of nursery care activities and modification of external stimuli) as well 
as the NIDCAP individualized developmental care approach. Although there was 
evidence of limited benefits of developmental care interventions and no major 
harmful effects reported, there were a large number of outcomes with no or con-
flicting results. The single developmental care trials that did show a significant 
effect of an intervention on a major clinical outcome were based on small sample 
sizes, and the findings were often not supported in other small trials10. More rand-
omized trials were recommended in which the effectiveness of developmental care 
programs can be evaluated. No studies have been carried out to examine a less 
intensive, more basic developmental care program.
 The aim of this randomized controlled trial (RCT) was to explore the effective-
ness of the implementation of elements of basic developmental care to reduce 
stress and improve physiological stability in preterm infants on neonatal morbidity, 
neuromotor development and growth at term age. 
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Methods
 The study was carried out from April 2000 to May 2002 at a tertiary NICU at 
2 locations in the Netherlands: Leiden University Medical Center in Leiden and 
Juliana Children’s Hospital in The Hague. The inclusion criteria was birth at a gesta-
tional age of < 32 (31+6) weeks. Exclusion criteria were major congenital anomalies, 
need for major surgery and having a drug-addicted mother.  After parental informed 
consent was obtained by the resident or staff member on call, infants were randomly 
assigned within 48 hours of birth to the DC group or the control group using sealed 
envelopes made in groups of 6 using a computer-generated randomization allo-
cation. According to protocol, infants in both groups who were admitted for less 
then 5 days were excluded from follow-up, because the duration of the basic DC 
intervention was hypothesized not to be long enough to obtain an effect. A power 
analysis performed before the study showed that a total sample size of 140 infants 
was needed to show a significant difference (p < .05) with a power of 80%; based 
on a difference of half a standard deviation on the developmental test scores at 1 
and 2 years of age, corrected for prematurity, and was deemed sufficient power for 
the short-term primary neonatal outcomes.
 The intervention included the reduction of light and sound through the use of 
standardized incubator covers and supporting motor development and physiologi-
cal stability by positioning the infant in ways that encourage flexion and containment 
through the use of standardized nests and positioning aids. Infants in the control 
group received standard care, which at that time consisted of no covers or nesting.
The Ethical Committees of both locations approved the study.
Definitions
 Severity of illness was analyzed using the CRIB (Clinical Risk Index for Babies) 
score which assesses initial neonatal risk. Scores are given for birth weight, gesta-
tional age, maximum and minimum fraction of inspired oxygen and maximum base 
excess during the first 12 hours, and the presence of congenital malformation11. 
Inborn infants were infants who were born in the participating tertiary neonatal 
center.
 The primary medical outcome variables included duration of respiratory support, 
number of days in intensive care and short-term growth. Mechanical ventilation 
and/or continuous positive airway pressure (CPAP) were measured in days. When 
an infant received both mechanical ventilation and CPAP in 1 day, the method of 
respiratory support given for the most hours was chosen. In addition, the total 
number of days of respiratory support was defined as total combined days of 
mechanical ventilation and CPAP. Discharge from the intensive care was based on 
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2 criteria: the infant required no mechanical ventilation and/or CPAP for 24 hours 
and weighed at least 1000 grams. 
 Infants were weighed at least biweekly; head circumference and length were 
measured within the first 2 days of life and thereafter weekly by trained medical 
students until the infant was either transferred or discharged. Short-term growth 
(weight, head circumference, length) was defined as measurement at birth and 
at term age as well as mean daily weight gain in grams and mean weekly length 
and head circumference growth in centimeters. Weight was measured on neonatal 
pediatric digital scales, length was measured from crown to heel and head circum-
ference was measured around the largest area of the head, occipital-frontal circum-
ference (OFC), using a non-stretch tape measure. 
 In addition, secondary outcomes were analyzed. Mortality was defined as early 
neonatal death when the infant died within the first 7 days of life and late neonatal 
death when the infant died after 7 days but before 28 days of life. Days of oxygen 
were calculated as total days of supplementary oxygen as well as the need for oxygen 
after 28 days of life.
 Bronchopulmonary dysplasia (BPD) was defined as oxygen dependency at 36 
weeks postconceptional age (PCA) according to the criteria of Shennan12. Postnatal 
steroids were divided into 3 classifications; 7 to 10, 15 to 20, and > 20 days. Intra-
ventricular hemorrhage (IVH) was recorded according to Volpe13.  Periventricular 
leukomalacia (PVL) was classified according to grades 1-414. Sepsis was based on 
a positive blood culture (congenital infections excluded). Meningitis was defined 
as a positive cerebrospinal fluid (CSF) culture and/or pleocytosis. In addition, the 
incidence of necrotizing enterocolitis (NEC), persistent ductus arteriousus (PDA), 
retinopathy of prematurity (ROP), need for treatment of hypotension and hyperbili-
rubinemia was analyzed. 
Follow-up
 At term age, infants were seen in the follow-up clinics to assess growth, morbidity 
and neuromotor development by neonatologists who were experienced in develop-
mental assessments and blinded to the group assignment of the infant. A standardized 
neurological examination according to Prechtl15 was administered and was defined 
as definitely abnormal (DA), mildly abnormal (MA) or normal. Definitely abnormal 
means the presence of a full-blown neonatal neurological syndrome, such as apathy 
or hyperexcitability, hypotonia or hypertonia, hyporeflexia or hyperreflexia, hypokine-
sia or hyperkinesia, or a hemi-syndrome. Mildly abnormal denotes the presence of 
only part of such a syndrome. Examples of minor neurological signs are abnormal 
posture, abnormal head control and absent or abnormal responses or reflexes.
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Statistical Analysis
 Data was analyzed using SPSS 12.0 for Windows (SPSS Inc, Chicago, IL). The 
infant and parent characteristics were compared with the Chi-square test, the 
Chi-square test for trend or the two-sample t-test, where appropriate. Outcome 
parameters were compared between the two treatment groups with the t-test, 
Mann-Whitney test or Chi-square test where appropriate. A p-value of < 0.05 was 
considered significant. Linear regression was used to evaluate the influence of the 
duration of the intervention on term age outcomes by testing whether there was an 
interaction effect between the intervention duration and the 2 treatment groups. 
Results
 In total, 192 infants were originally included for the study: 98 in the DC group 
and 94 in the control group. Thirteen infants (DC: 7; control: 6) were excluded 
according to protocol because they were admitted less than 5 days or died within 
the first 5 days. One of the 6 infants in the control group was taken out of the study 
on day 3 at the parents’ request. This left a total of 179 infants who met inclusion 
criteria. Of the 179 included infants, 12 (13.2%) of 91 in the DC group and 8 (9.1%) 
of 88 in the control group died during hospitalization, with the main cause of death 
being cerebral or pulmonary complications. The difference between the 2 groups 
was not significant (p=0.40). Two infants in each group died of NEC. One infant 
was lost to follow-up in the DC group and 5 infants in the control group because 
either they were transferred to hospitals out of the health region or parents did not 
want to come back for follow-up. Two infants from the DC group and 2 from the 
control group did not show up for the term age follow-up assessment, resulting in 
76 infants in the DC group and 73 infants in the control group who were assessed at 
the outpatient clinic. All infants who were lost to follow-up survived. The mortality 
rate and loss to follow-up are shown in Figure 1. The data from the infants who were 
lost to follow-up were comparable to the infants who were assessed at follow-up 
(data not shown).
 Parent characteristics for the study population were similar, with no significant 
differences found, and are shown in Table 1. There was no difference in infant 
characteristics between the DC and the control group, with the exception of more 
infants in the control group with grade 4 RDS, however the difference was not sig-
nificant (Table 2).
 Some of the infants were transferred to regional hospitals once stabilized. Seven 
infants (DC: 5; control: 2) were hospitalized temporarily elsewhere for surgical or 
other necessary treatment. These infants were included in the outcome under the 
intention-to-treat protocol. 
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Infants at follow-up at term age: 76 Infants at follow-up at term age: 73
3 infants loss to follow-up
- 1 infant followed elsewhere
- 2 infants did not show up to 
  follow-up clinic
7 infants loss to follow-up
- 5 infants followed elsewhere
- 2 infants did not show up to 
  follow-up clinic
Remaining infants: 79 Remaining infants: 80
12 infant deaths 8 infant deaths
91 infants included 88 infants included
7 infants excluded due to admission 
< 5 days
- 1 infant death
- 6 infants transferred
6 infants excluded due to admission 
<  days
- 3 infant deaths
- 2 infants transferred
- 1 infant out study on day 3 at 
  parents request
98 DC group 94 C group
192 infants recruited
Infants in Developmental Care Study
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Table 1. Maternal medical and parental demographic background variables
DC 
n=91   
Control 
 n=88
Obstetrical history
Pre-existing disease
(diabetes, renal, hypertension, other) 8/82 (9.8) 11/82 (13.4)
Pregnancy induction 13/86 (15.1) 12/84 (14.3)
Diseases during pregnancy 
Diabetes mellitus gravidarum
(Pre)eclampsia or HELLP syndrome
4/87 (4.6)
19/87 (21.8)
5/84(6.0)
13/84 (15.5)
Medication  during pregnancy
Antihypertensives
Antibiotics
Tocolytics 
Other
Antenatal glucocorticoids
1 dose
1 course (2 doses)
12/91 (13.2)
35/91 (38.5)
46/91 (50.5)
8/91 (8.8)
17/90 (18.9)
47/90 (52.2)
14/84 (16.7)
34/84 (40.5)
48/84 (57.1)
7/84 (8.3)
28/88 (31.8)
41/88 (46.6)
Mode of delivery
Vaginal
Caesarean section
51/91 (56.0)
40/91 (44.0)
47/88 (53.4)
41/88 (46.6)
PROM > 24 hours 16/91 (17.6) 22/88 (25.0)
Primipara 76/91 (83.5) 73/86 (84.9)
Parental demographic background
Maternal age 
(mean in years, sd)
Paternal age 
(mean in years, sd)
n=89
30.1 (5.6)
n=70
34.3 (5.3)
n=85
30.4 (5.1)
n=69
35.0 (5.7)
Mother Caucasian
Father Caucasian
59/90 (65.6)
63/90 (70.0)
62/87 (71.3)
65/87 (74.7)
Mother’s education level* 
Low
Intermediate
High
36/78 (46.2)
26/78 (33.3)
16/78 (20.5)
24/73 (32.9)
33/73 (45.2)
16/73 (21.9)
Father’s education level*
Low
Intermediate
High
30/78 (38.5)
30/78 (38.5)
18/78 (23.0)
21/73 (28.8)
29/73 (39.7)
23/73 (31.5)
Data shown is n (%), unless otherwise indicated 
HELLP indicates hemolysis, elevated liver enzymes, and low platelet count; PROM: premature rupture of 
membrane
* Low indicates vocational training, intermediate = high school, high = college/university
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Table 2. Infant medical background variables
Birth Characteristics
DC 
n=91
Control
n=88
Gestational age, wk 
Mean (SD) 
Range
n=91
29.3 (1.8)
25.0-31.9
n=88
28.9 (1.9)
25.0-31.9
Birthweight,g 
Mean (SD)
Range
n=91
1216 (358)
538-2155
n=88
1196 (354)
640-2080
Length,cm  
Mean (SD)
Range
n=79 
37 (4.0)
25.0-46.0
n=79
37 (3.8) 
28.5-45.0
Head circumference 
Mean in cm, sd
Range
n=86
26.7 (2.4) 
22.0-33.6 
n=86
26.5 (2.3)
22.0-31.6
Male gender 49/91 (54.0) 58/88 (65.9)
SGA p < 10 and p ≥ 3 
SGA p < 3
8/91 (8.8)
8/91 (8.8)
8/88 (9.1) 
6/88 (6.8)
Twin 26/91 (28.6) 18/88 (20.5)
Inborn 56/91 (61.5) 53/87 (60.9)
Apgar scores at 5 minutes
Mean (SD)
Median (range)
8.1 (1.8)
9 (2-10)
8.1 (1.4)
8 (3-10)
CRIB Score 
Median (range)
RDS 
Grade 1
Grade 2
Grade 3
Grade 4
Surfactant 
Hyperbilirubinemia
n = 91
2 (0-20)
15/91 (16.5)
16/91 (17.6)
19/91 (20.9)
  9/91 (9.9)
41/91 (45.1)
82/91 (90.1) 
n = 87
3 (0-12)
15/87 (17.2)
17/87 (19.5)
14/87 (16.1)
17/87 (19.5)
50/88 (57.5)
81/88 (92.0)
Data shown is n (%), unless otherwise indicated
SGA indicates small for gestational age;  p: percentile; CRIB: Clinical Risk Index for Babies; RDS: respiratory 
distress syndrome
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Primary outcomes
 No significant difference was found in the number of intensive care days, days of 
respiratory support or growth between the DC and control groups (Table 3). Eighty-
six (94.5%) infants in the DC group and 79 (89.8%) infants in the control group 
required some form of respiratory support. A total of 149 infants (DC: 76; control: 
73) of the surviving 159 (93.7%) infants were seen at the follow-up clinic at term age. 
One infant was too ill to undergo a Prechtl examination. No significant difference 
was found in the neurological outcomes between the DC and control groups. Of 
the 149 infants, 4 in the DC group and 3 in the control group were not measured or 
weighed at term age. Four surviving infants (DC: 3; control: 1) who had a diagnosis 
of post-hemorrhagic ventricular dilatation were excluded from the weekly and term 
age head circumference analysis. No significant difference was found between the 
DC and control groups in the growth parameters at term age or in daily weight gain 
(g), and weekly length and head circumference (cm) growth.
 We also conducted a linear regression analysis to determine whether the number 
of days when infants received the DC intervention influenced the neuromotor 
outcome according to Prechtl and growth at term age by testing whether there 
was an interaction effect between the intervention duration and the 2 treatment 
groups. No significant effect on the neuromotor outcome (p=0.45), term age head 
circumference (p=0.56): term age weight (p=0.61) or term age length (p=0.92) was 
found.
Secondary outcomes
 A total of 15 (19.2%) of 78 infants in the DC group required oxygen after 28 days 
of life as opposed to 22 (29.3%) of 75 infants in the control group; however, the 
difference was not significant (p=0.15). No difference was found in the incidence 
of BPD between the 2 groups. In total 4 (4.4%) of 91 infants in the DC group 
required postnatal corticosteroids as opposed to 10 (11.4%) of 88 infants in the 
control group (p=0.08). A total of 19 (20.9%) of 91 infants in the DC group had 
grade 1 or 2 IVH as opposed to 28 (31.8%) of 88 in the control group, and twice as 
many infants (11 of 91 [12.1%]) in the DC group had grade 3 IVH or grade 3 IVH and 
periventricular echodensity than in the control group (5 of 88 [5.7%]; p=0.12). At 
term age, there was no difference in the incidence of PVL or the number of infants 
who required physical therapy. Also, no significant differences were found in the 
remaining secondary outcomes (Table 4).
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Table 3. Comparison of data of primary outcome measures 
DC 
n=91
Control
n=88
p-value
Days of hospitalization
Mean (SD)
Median (range)
37.2 (29.1)
31 (6-142)
36.4 (28.1)
30 (5-165)
0.86
Days intensive care
Mean (SD)
Median (range)
15.9 (13.7)
12 (0-53)
16.7 (15.3)
11 (0-60)
0.74
No. of infants requiring respiratory support 86/91 (94.5) 79/88 (89.8) 0.28
Days of mechanical ventilation 
Mean (SD)
Median (range)
Days of CPAP 
Mean (SD)
Median (range)
Total days ventilatory support
Mean (SD)
Median (range)
6.1 (7.3)
3.5 (0-39)
8.6 (9.6)
4.5 (0-35)
14.6 (13.6)
10.0 (1-52)
6.9 (7.1)
4.0 (0-29)
10.1 (10.5)
6.0 (0-39)
17.0 (15.1)
12.0 (1-59)
0.45
0.34
0.30
Growth parameters at term age 
Age, mean (SD), wk 
Weight, mean (SD), kg
Head circumference*, mean (SD), cm 
Length, mean (SD), cm
Daily weight gain, mean(SD), g
Weekly head circumference growth*, 
    mean (SD), cm
Weekly growth in length, mean (SD), cm 
n = 72
40.8 (1.2)
3.12 (0.64)
35.6 (1.8)
48.6 (3.3)
23.7 (4.9)
0.78 (0.13)
1.00 (0.23)
n  = 70
40.7 (1.5)
3.15 (0.50)
35.5 (1.6)
48.6 (2.3)
23.6 (4.8)
0.75 (0.14)
0.97 (0.20)
0.72
0.76
0.81
0.95
0.95
0.38
0.34
Neurological outcome at term (Prechtl)
Normal
Mildly abnormal
Definitely abnormal
42/76 (55.3)
30/76 (39.5)
 4/76 (5.2)
43/72 (59.7)
27/72 (37.5)
 2/72 (2.8)
0.46
Data shown is n (%), unless otherwise indicated
Comparisons were performed by using chi-square test (for linear trend), t-test or Mann-Whitney test where 
appropriate
*  Infants with posthemorrhagic ventricular dilatation (DC: n=3,control: n=1) were excluded from head circum-
ference analysis
Chapter 3
48
Table 4. Comparison of data of secondary outcome measures
DC
n=91
Control
n=88
p-value
In-hospital mortality
 Early neonatal death
 Late neonatal death
12/91 (13.2)
3/91 (3.3)
9/91 (9.9)
8/88 (9.1)
2/88 (2.3)
6/88 (6.8)
0.40
Total days supplemental oxygen  
 Mean (SD)
 Median (range)
Oxygen requirement > 28 days of life 
BPD (oxygen dependent > 36 wk GA)
12.0 (17.7)
  5 (0-93)
15/78* (19.2) 
6/78 (7.7)
14.9 (20.5)
  4.5 (0-90) 
22/75* (29.3)
10/75 (13.3)
0.31
0.15
0.30
Postnatal corticosteroids 
 7-10 days
 15-20 days 
 > 20 days
2/91 (2.2)
1/91 (1.1)
1/91 (1.1)
1/88 (1.1)
8/88 (9.1)
1/88 (1.1)
0.08
IVH
 Grade 1-2
 Grade 3 and periventricular echodensity
Posthemorrhagic ventricular dilation
19/91 (20.9)
11/91 (12.1)
4/91 (4.4)
28/88 (31.8)
5/88 (5.7)
2/88 (2.3)
0.12
0.68
NEC
Sepsis
Meningitis
PDA (indomethacin and/or surgery)
Dopamine/Dobutamine
ROP
6/91 (6.6)
40/91 (44.0)
5/91 (5.5)
19/91 (20.9)
32/91 (35.2)
3/70 (4.3)
4/87 (4.6)
32/87 (36.8)
5/88 (5.7)
23/88 (26.1)
25/87 (28.7)
5/70 (7.1)
0.75
0.36
0.99
0.48
0.42
0.19
PVL   at term age follow-up 
 Grade 1
 Grade 2
 Grade 3
 Grade 4
Physical therapy required at term 
 3/71 (4.2)
 3/71 (4.2)
 0/71 (0.0)
 0/71 (0.0)
14/76 (18.4)
6/67 (9.0)
3/67 (4.5)
0/67 (0.0)
0/67 (0.0)
9/74 (12.2)
0.53
0.49
Data shown is n (%), unless otherwise indicated
Comparisons were performed by using the chi-square test (for linear trend) or t-test where appropriate
* n is lower as a result of in-hospital deaths and loss to follow-up infants
BPD indicates bronchopulmonary dysplasia; GA: gestational age; IVH: intraventricular haemorrhage; NEC: 
necrotising enterocolitis; PDA: patent ductus arteriosus;  ROP: retinopathy of prematurity; PVL: periventricu-
lar leukomalacia
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Discussion
 In this RCT to examine the short-term effects of basic DC (incubator covers, 
nests and positioning aids) on neonatal morbidity, neuromotor development and 
growth at term age of infants who were born at < 32 weeks gestation, we found no 
significant positive effects of the intervention on intensive care days or need for 
respiratory support. Although the control infants had more pulmonary problems 
than the infants in the DC group, the difference was not significant. There were 
also no differences between the DC and control groups in growth and neurological 
outcomes at term age, even when correcting for days of intervention. This study 
is to our knowledge the largest RCT to examine the effects of basic developmental 
care on preterm infants. Of the surviving 159 infants, 93.7% were seen at follow-up 
at term age. 
 The Cochrane Review10 looked at 4 separate developmental care interventions 
(positioning, clustering of care, modification of external stimuli and individualized 
developmental care), but no studies that combined nesting, positioning aids and 
incubator covers have been published to our knowledge. Because NICU’s may start 
with these basic elements when embarking on the implementation of a develop-
mental care program, we believed that it was important to study the effects of these 
basic interventions. Most previous RCT’s examined the effects of the more intensive, 
individually-focused NIDCAP program and although a few of them showed positive 
results 16-21, we were not able to duplicate this with the less intensive basic develop-
mental care. 
 One limitation of our study was the variation in total days of hospital admission 
of studied infants. In the Netherlands’ neonatal care system, infants may be trans-
ferred to regional hospitals once they no longer require intensive care. This was 
also the case with a number of infants in our study. This would not affect the short-
term outcomes such as days of intensive care or respiratory support, because all 
infants remained in the participating hospitals during this period, but could have 
an effect on growth and secondary outcomes at term age. If this were true, then 
infants who received more days of developmental care would show less morbidity 
and better short-term growth and neurodevelopmental outcome; however, our 
analysis showed that this was not the case. It seems that at least concerning short-
term outcomes, the duration of providing basic developmental care, whether only 
during the intensive care period or continuing developmental care until hospital 
discharge, has no significant effect.
 The infants were randomly assigned in an appropriate manner; however, there 
could be no blinding of the intervention because the infants in de DC group had 
incubator covers and nesting. This did make it easier to ensure a strict control 
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group whereby control infants were not provided with any nesting or incubator 
covers, because this was the standard method of care when this trial began and so 
was easy to maintain during the study period. The amount of respiratory support 
given to an infant was decided on by several neonatologists and so was not influ-
enced by the study group in which the infant was placed. Because the discharge 
from the intensive care was based on two criteria: the infant’s requiring no mechan-
ical ventilation and/or CPAP for 24 hours and weight at least 1000 grams, IC days 
also could not be influenced by group participation. In addition, the neonatologists 
who performed the term age assessments were blinded to group participation.
Conclusions
 This was a RCT with a large sample size in comparison with previous devel-
opmental care studies; however, no significant results were found. Our findings 
showed that a less intensive, cost-saving form of developmental care (incubator 
covers, nests and positional aids) does not have a significant effect on short-term 
medical outcomes (respiratory support, intensive care days), growth or neurode-
velopment at term age. Although some of the secondary analyses were suggestive 
of an advantage to developmental care, they did not reach a level of significance 
and would therefore need to be replicated in a larger sample to confirm a trend. 
Additional research of the developmental outcomes at 1 and  2 years of age of the 
children in this study will be addressed in future publications.
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Abstract
Objective: Randomized controlled trial investigating the effect of basic elements 
of developmental care (DC) on growth and neurodevelopment in infants born < 32 
weeks.
Study design: Infants were randomized within 48 hours of birth to DC group or 
standard care (C) group. Outcome measures at 1 and 2 years corrected age (CA) 
were growth, standardized neurological exams and mental (MDI) and psychomo-
tor (PDI) development (Dutch version of the Bayley Scales of Infant Development 
II). Outcome parameters were compared with the t-test, Mann-Whitney test or Chi-
square test where appropriate. Linear regression was used to evaluate the influence 
of the duration of the intervention on 1 and 2 year outcomes.  
Results: 192 infants were recruited (DC=98; C=94). Thirteen infants (DC=7, C=6) 
were excluded because they were admitted less than or died within the first 5 days. 
In total, 179 infants met inclusion criteria. In-hospital mortality was 12/91 (13.2%) 
in DC group and 8/88 (9.1%) in C group. 147 children (DC= 74, C= 73) at 1 year and 
142 children (DC=72, C=70) at 2 years were assessed. No significant difference in 
growth, neurological outcomes or MDI was found. A positive trend in PDI at 1 year 
(p=0.05) did not continue once the children reached 2 years. When neurological 
and developmental scores were combined, the C group showed more definitely 
abnormal scores than the DC group at both ages, but this did not reach the level 
of significance. 
Conclusions: Basic developmental care has a positive effect on psychomotor devel-
opment at 1 CA, but this improvement does not continue at 2 years CA in infants 
born < 32 weeks. No significant difference in neurological and mental development 
or growth was found. 
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Introduction
 The care and survival rate of preterm born infants has in recent years continued 
to improve 1-4.  Even as survival rates are improving, the risk of developmental dis-
abilities remains high and increases as the gestational age at birth decreases 1,5-7. 
The technological advances are improving the survival rates of preterm infants, but 
the question remains how these vulnerable infants can best be supported during 
their stay in the neonatal intensive care unit (NICU) in order to positively influence 
their developmental outcomes. Since the 1980’s, programs have been created to 
support the infant’s development in the NICU while at the same time providing the 
necessary medical and nursing interventions. Many of these programs are based 
on developmental care, with the most comprehensive being the Newborn Individu-
alized Developmental Care and Assessment Program (NIDCAP) developed by Als, 
an individual approach in which caregiving is based on the infant’s behavior 8,9. 
The first studies of  the effectiveness of the NIDCAP developmental care program 
in the 1980’s and 1990’s showed promising results, however the sample size of 
the studies was small 10-14. Follow-up studies published to date up to preschool age 
have been scarce and the results are conflicting10,15-18. In a recent Cochrane review 
of developmental care the need for larger trials, more follow-up and studying the 
effects of different aspects of developmental care was emphasized 19. 
 The aim of this randomized controlled trial (RCT) was to explore the effec-
tiveness of the implementation of basic Developmental Care on growth, mental 
and psychomotor development and neurological outcome at 1 and 2 years CA of 
preterm infants born < 32 weeks gestational age. We hypothesized that by reducing 
stress and promoting physiological stability through the use of incubator covers 
and nesting, the stability provided to the infants during their NICU hospitalization 
would positively affect their later growth and development.  
Patients and Methods
 The study was carried out from April 2000 to June 2004 at a tertiary NICU at 
2 locations in the Netherlands: Leiden University Medical Center in Leiden and 
Juliana Children’s Hospital in The Hague. Inclusion criteria were: infants born with 
a gestational age < 32 (31+6) weeks. Exclusion criteria included: infants with major 
congenital anomalies, infants needing major surgery and infants of drug-addicted 
mothers.  After parental informed consent was obtained by the resident or staff 
member on call, infants were randomized within 48 hours of birth to the Devel-
opmental care (DC) group or the Control (C) group using sealed envelopes made 
Chapter 4
56
in groups of 6 using a computer generated randomization allocation. According 
to protocol, infants in both groups who were admitted for less than 5 days were 
excluded from follow-up because the duration of the basic developmental care 
intervention was hypothesized not to be long enough to obtain an effect. A power 
analysis performed before the study showed that a sample size of 140 infants was 
needed to show a significant difference (p level < .05) with a power of 80%, based 
on the expected difference of half a standard deviation (7.5) on the developmental 
test scores at 1 and 2 years corrected age (CA). 
 The intervention included the reduction of light and sound through the use of 
standardized incubator covers and supporting motor development and physiologi-
cal stability by positioning the infant in ways that encourage flexion and contain-
ment through the use of standardized nests and positioning aids. Infants in the 
control group received standard care, which at that time consisted of no covers or 
nesting20. The Ethical committees of both locations approved the study. 
Measures
 Infant characteristics (gestational age, birth weight, gender, small for gestational 
age, inborn, Apgar scores, CRIB score) and parental characteristics (age, ethnicity, 
educational level) were collected to compare groups (Tables 1 and 2). Inborn infants 
were infants born in the participating tertiary neonatal center. Severity of illness was 
analyzed using the CRIB (Clinical Risk Index for Babies) score which assesses initial 
neonatal risk. Scores are given for birth weight, gestational age, maximum and 
minimum fraction of inspired oxygen and maximum base excess during the first 12 
hours, and the presence of congenital malformation 21. 
Follow-Up
 Children were assessed at 1 and 2 years of corrected age for prematurity (CA) 
for growth and neurodevelopment by neonatologists experienced in developmen-
tal assessments and blinded to the group assignment of the child. A standardized 
neurological exam according to Touwen 22,23 at one year CA and Hempel 24  at two 
years CA was administered and classified as definitely abnormal (DA) when there 
was definite neurological dysfunction such as cerebral palsy; mildly abnormal (MA) 
in the presence of mild deviations in muscle tone regulation, reflexes, fine or gross 
motor performance or cranial nerve function; or normal (N). 
 Weight was measured on a pediatric digital scale, length was measured from 
crown to heel on a standard measurement board and head circumference was 
measured around the largest area of the head, occipital-frontal circumference 
(OFC), using a non-stretch tape measure. 
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 In addition, children were assessed at 1 and 2 years CA by psychology interns 
supervised by a clinical psychologist, who were blinded as to whether the child was 
in the DC or C group. Mental and psychomotor development was assessed using 
the Dutch version of the Bayley Scales of Infant Development II (BSID-II)25,26. The 
mean score of the mental developmental index (MDI) and the psychomotor devel-
opmental index (PDI) is 100, with 1 standard deviation (SD) of 15 points. An MDI 
or PDI ≥ 85 (≥ – 1 SD) is considered normal, an MDI or PDI between 70 and 84 (–2 
to –1 SD) is considered mildly delayed and Index scores ≤ 69 (< – 2 SD) severely 
delayed. The Dutch norms, which had become available during our research, were 
used. To obtain a single outcome measure, neurological outcome, PDI and MDI 
were combined. When at least 1 of these 3 outcome measures was DA, children 
were considered DA, and when at least 1 outcome was MA, children were consid-
ered MA.
Statistical Analysis
 Data was analyzed using SPSS 12.0 for Windows. The infant and parent char-
acteristics were compared with the Chi-square test, the Chi-square test for trend 
or the two-sample t-test, where appropriate. Outcome parameters were compared 
between the two treatment groups with the t-test, Mann-Whitney test or Chi-square 
test where appropriate. P-values < 0.05 were considered significant. Linear regres-
sion was used to evaluate the influence of the duration of the intervention on 1 and 
2 year outcomes by testing if there was an interaction effect between the interven-
tion duration and the 2 treatment groups. 
Results
 In total 192 infants were recruited for the study; 98 in the DC group and 94 in the 
C group. Thirteen infants (DC=7, C=6) were excluded according to protocol because 
they were admitted less than 5 days or died within the first 5 days. One of the six 
infants in the C group was taken out of the study on day 3 at parents’ request. This 
left a total of 179 infants that met inclusion criteria. Of the 179 included infants, 
12/91 (13.2%) in the DC group and 8/88 (9.1%) in the C group died during hospital-
ization, with the main cause of death being cerebral or pulmonary complications. 
Two infants in each group died of NEC. There was no significant difference in the in-
hospital mortality rate between the DC and C group (p=0.40). This left a remaining 
159 infants (DC=79, C=80) for follow-up. At the 1 year assessment, there were 4 
infants lost to follow-up in the DC group and 7 infants in the C group because they 
were either transferred to hospitals out of the health region or parents did not want 
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Infants at follow-up at 2 years CA: 72 Infants at follow-up at 2 years CA: 70
1 infant died after term age
4 infants loss to follow-up 7 infants loss to follow-up
Remaining infants: 79 Remaining infants: 80
12 infant deaths 8 infant deaths
91 infants included 88 infants included
7 infants excluded due to admission
   < 5 days
- 1 infant death
- 6 infants transferred
6 infants excluded due to admission
   < 5 days
- 3 infant deaths
- 2 infants transferred
- 1 infant out study on day 3 at 
  parents request
98 DC group 94 C group
192 infants recruited
Infants in Developmental Care Study
2 infants  loss to follow-up 3 infants loss to follow-up
Infants at follow-up at 2 years CA: 72 Infants at follow-up at 2 years CA: 70
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to come back for follow-up. In addition, one infant in the DC group died between 
term age and 1 year. Between the 1 and 2 year assessment 2 children in the DC 
group and 3 children in the C group were lost to follow-up due to parents moving 
or not wanting to continue with the follow-up. The baseline data from the lost to 
follow-up infants was comparable to the infants that were assessed at follow-up 
(data not shown). There were 147 children: DC=74/79 (93.7%), C= 73/80 (91.3%) at 
1 year corrected age and 142 children: DC=72/79 (91.1%), C=70/80 (87.5) at 2 years 
corrected age that were seen at the follow-up clinic of the total 159 surviving infants. 
The mortality rate and loss to follow up are shown in Figure 1.
 There was no significant difference in infant characteristics between the DC and 
C groups assessed at 1 year or 2 years (Table 1). Parent characteristics (age, ethnicity 
and educational level) were similar in both groups with no significant differences 
found and are shown in Table 2.
Table 1. Infant medical background variables of children seen at 1 and 2 year follow-up 
DC
n (%)
C
n (%)
DC
n (%)
C
n (%)
1 year 2 years
Birth Characteristics n=74 n=73 n=72 n=70
Gestational age mean in 
wks (sd )
      range
29.5 (1.6)
25.9-31.9
29.1 (1.9)
25.0-31.9
29.5 (1.6)
25.9-31.9
29.1 (1.9)
25.0-31.9
Birthweight mean in g, (sd) 
      range
1248.4 (338.1)
(585-2155)
1238.5 (337.2)
(640-2080)
1266.3 (329.6)
(585-2155)
1236.6 (338.5)
(640-2080)
Male gender 39/74 (52.7)  46/73 (63.0) 38/72 (52.8)  44/70 (62.9)
SGA*
      SGA P < 10 and P ≥ 3
      SGA P < 3
8/74 (10.8)
6/74 (8.1)
6/73 (8.2) 
4/73 (5.5)     
8/72 (11.1)
4/72 (5.6)
5/70 (7.1) 
4/70 (5.7)     
Inborn 46/74 (62.2) 46/72 (63.9)  45/72 (62.5) 44/70 (63.8)  
Apgar scores at 5 minutes 
     median (range)
n= 74   
9.0 (2-10)
n= 72†
8.0 (5-10)
n= 72   
9.0 (2-10)
n= 69†
8.0 (5-10)
CRIB Score mean (sd)*
    range
3.2 (2.9)
0-13
3.7 (2.9)
0-11
3.0 (2.7)
0-10
3.8 (3.0)
0-11
Data shown is n (%), unless otherwise indicated
Comparisons were done using chi-square test or t-tests where appropriate
* SGA: small for gestational age, P: percentile, CRIB: Clinical Risk Index for Babies
† Correct n is shown in table if there are missing values
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Growth
 One child from the C group was not measured at 1 year of age. At 2 years of age 
one child from the DC group and one child from the C group were not measured. 
There was no significant difference found between the DC and C group in growth 
(weight in grams, height and head circumference in centimeters) at 1 or 2 years CA. 
When we calculated the standard deviation scores (SDS) using the Dutch growth 
charts, the DC group showed significantly better SDS for length than the C group 
and the weight (p=0.08) and head circumference (p=0.06) SDS showed a trend in 
favor of the DC group. There were however more infants in the C group (11.3 %) 
than in the DC group (4.4 %) that required postnatal corticosteroids (p=0.08), the 
usual dosage being 0.20 mg/kg/day in 2 doses with tapering of the dosage over a 
period of 16 days. As this may influence growth we corrected for use of postnatal 
steroids and then found no significant difference in growth SDS between the 2 
groups (Table 3).
Table 2. Parental demographic background variables 
DC
n (%)
C
n (%)
DC
n (%)
C
n (%)
1 year follow-up 2 year follow-up
Maternal age 
     mean in years (sd)
n=74
31.3 (5.1)
n=73
31.4 (4.9)
n=72
32.5 (5.1)
n=73
31.4 (4.9)
Paternal age
     mean in years (sd)
n=70
34.3 (5.3)
n=69
35.0 (5.7)
n=67
35.0 (5.2)
n=69
35.0 (5.7)
Mother Caucasian
Father Caucasian
48/74 (64.9)
52/74 (70.3)
53/73 (72.6)
56/73 (76.7)
48/74 (64.9)
52/74 (70.3)
53/73 (72.6)
56/73 (76.7)
Education level mother*
     low
     intermediate
     high
34/74 (46.0)
24/74 (32.4)
16/74 (21.6)
23/72 (32.0)
33/72 (45.8)
16/72 (22.2)
32/71 (45.1)
23/71 (32.4)
16/71 (22.5)
23/72 (32.0)
33/72 (45.8)
16/72 (22.2)
Education level father*
     low
     intermediate
     high
26/74 (35.2)
30/74 (40.5)
18/74 (24.3)
19/71 (26.8)
29/71 (40.8)
23/71 (32.4)
26/71 (36.6)
28/71 (39.4)
17/71 (23.9)
19/71 (26.8)
29/71 (40.8)
23/71 (32.4)
Data shown is n (%), unless otherwise indicated
Comparisons were done using chi-square test (for linear trend) or t-tests where appropriate
* Low = vocational training, intermediate = high school, high = college/university
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Developmental outcomes
 At one year of age 145 children (DC=73, C=72) of the 147 children seen at follow-
up were tested with the Bayley Scales-II-NL and at 2 years of age 140 (DC=70, 
C=70) of the 142 children seen at follow-up were tested. There were 3 children 
(DC=1, C=2) who were 13 or 14 months CA at the 1 year developmental follow-up 
and 8 children (DC=4, C=4) tested  that were 26-27 months CA at the 2 year devel-
opmental follow-up, but their index scores were based on the norms for that age so 
we included them in the analysis. There was no significant difference in the mean 
age of all children assessed at the 1 and 2 year follow-up.
There were 2 children who did not have a developmental test due to illness or 
because they were uncooperative. At one year CA, the children in the DC group 
showed a trend of improvement (p=0.05) in the psychomotor developmental index 
(PDI) as compared to the C group but no significant difference (p=0.56) in their 
mental developmental index (MDI). At 2 years CA, this difference was no longer 
evident as both the MDI and PDI scores were comparable. While the PDI classifica-
tions at 12 and 24 months had a higher percentage of children in the C group with 
severe delays, this difference was not significant (p=0.27; p=0.20) (Table 4). 
Neurological outcomes
 There were 147 (DC=74, C=73) children who were assessed with a neurological 
exam at 1 year CA and 140 (DC=71, C=69) children at 2 years CA. Two children 
(DC=1, C=1) were not able to be tested at 2 years CA because they were uncoop-
erative. There was no significant difference found between the DC and C group in 
neuromotor development at 1 year and 2 years CA. Although there were twice as 
many children in the C group with definitely abnormal scores at 1 year and more 
than 3 times as many C children at 2 years of age, the difference was not significant 
(Table 5). 
Combining neurological development, MDI and PDI scores in a Total Outcome 
Score
 When we combined the developmental and neurological score, the percentage 
of C group children that were definitely delayed at both 1 and 2 years compared 
to the DC group was much higher (1 year: DC=12.2%, C=23.3%; 2 year: DC=5.6%, 
C=18.3%), however the difference did not reach the level of significance (Table 5). 
We then carried out a linear regression analysis to see if the number of days infants 
received the DC intervention influenced the neurological outcomes at 1 and 2 
years according to Touwen and Hempel by testing if there was an interaction effect 
between the intervention duration and the two treatment groups. There was no 
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significant effect on the neurological outcome at 1 year (p=0.79) or 2 years (p=0.67) 
or on the combined neurological and developmental scores at 1 year (p=0.86) and 
2 years (p=0.60) found. 
Table  5.  Neurological outcomes and combined score of neurological outcomes, MDI and PDI at 
1 and 2 years corrected age (CA)
1 year CA 2 years CA
DC
n  (%)
C
n  (%)
DC
n  (%)
C
n  (%)
Neurological Outcome* Neurological Outcome*
n=74 n=73 p value n=71 n=69 p value
- N†
- MA
- DA
56 (75.7)
13 (17.5)
5 (6.8)
52 (71.2)
10 (13.7)
11 (15.1)
0.25 - N
- MA
- DA
50 (70.4)
17 (24.0)
4 (5.6)
46 (66.7)
11 (15.9)
12 (17.4)
0.18
Combined neurological 
score 
MDI and PDI
Combined neurological 
score
MDI and PDI‡
n=74 n=73 n=72 n=71
- N†
- MA
- DA
48 (64.8)
17 (23.0)
9 (12.2)
45 (61.6)
11 (15.1)
17 (23.3)
0.26 - N
- MA
- DA
38 (52.8)
30 (41.7)
4 (5.6)
37 (52.1)
21 (29.6)
13 (18.3)
0.25
Comparisons were done using chi-square test (for linear trend) where appropriate
* neurological exam according to Touwen at 1 year and Hempel at 2 years
† N=normal, MA=mildly abnormal, DA=definitely abnormal (MDI/PDI scores ≥ 85 = N, 70-84=MA, ≤69=DA)
‡  one DC group child’s en 2 C group children’s combined scores were derived from the PDI and MDI 
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Discussion
 This randomized controlled trial showed that basic developmental care 
(incubator covers and positioning aids) for infants born < 32 weeks gestational age 
has a positive effect on psychomotor development at 1 CA, but this improvement 
does not continue at 2 years CA and no significant effect on MDI at 1 and 2 years 
CA.  There may be some positive influence on neurological outcomes at 1 and 2 
years as there were more DA scores in the C group than in de DC group; however 
the effect was not statistically significant. 
 There were also some differences seen between the neuromotor and the devel-
opmental scores. While the percentages of children scoring severely delayed on 
the PDI were comparable with scores of definitely abnormal on the Touwen exam 
at 1 year of age, there were twice as many children in the C group who scored 
‘definitely abnormal’ in the Hempel neuromotor exam than children that scored 
‘severely delayed’ in the PDI of the Bayley exam at 2 years of age. One explanation 
for this discrepancy is that the Touwen and Hempel measure qualitative minor neu-
romotor dysfunction whereas the BSID-II PDI measures motor skills and identifies 
motor delays and gives a quantitative score. We therefore combined the scores into 
a single ‘mildly abnormal’ or ‘definitely abnormal’ score in order to get a clearer 
picture of the outcomes. We observed more children in the C group with scores 
of definitely abnormal; however the difference was not significant. There appeared 
to be a shift to mildly abnormal in the DC group as both groups had comparable 
percentages of normal scores. 
 In addition, we looked at the amount of days infants had received developmental 
care when hospitalized to see if that positively influenced neurological and develop-
mental outcomes at 1 and 2 years, but found no interaction effect. 
 To get a better picture of the growth outcomes, we corrected growth for CA by 
using standard deviation scores (SDS), which did show a significant improvement 
in length at 2 years in the DC group and a trend in improved head circumference 
growth at 2 years. However once SDS was corrected for postnatal steroid use, these 
differences were no longer apparent.
 To date, there has been no large RCT examining growth and neurodevelopmental 
outcome of a basic developmental care program. Therefore comparison to other 
studies is not possible. Most of the studies examined the more intensive individu-
alized NIDCAP developmental care program and had smaller sample sizes and 
mixed results 15-17,19. Most outcomes of developmental care studies have focused 
on short term morbidity and growth or neurodevelopment up to 9-12 months11,15,17 
with only one study that followed the infants’ development to 3 years which showed 
no significant difference in development between the two groups16. There were no 
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studies reported in the Cochrane meta-analysis examining the effect of basic devel-
opmental care programs such as ours on neurodevelopment19.  
 We have tried with this study to answer some of the questions posed concern-
ing developmental care and follow-up to 2 years of age. The percentage of lost 
to follow-up was low and the assessors were blinded to the treatment group the 
children participated in and the neurological outcomes were obtained using a stan-
dardized neurological examination. 
 Our conclusion is that a less intensive, cost-saving form of developmental care 
has a positive effect on psychomotor development at 1 year of age but no signifi-
cant effect on neurodevelopment of preterm infants at 2 years of age. Perhaps a 
more intensive, individualized developmental care program such as the NIDCAP 
program based on a larger sample size than previous studies will show improved 
outcomes.
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Abstract
Objective: To investigate the effect of the Newborn Individualized Developmen-
tal Care and Assessment Program (NIDCAP) on days of respiratory support and 
intensive care, growth and neuromotor development at term age in infants born < 
32 weeks.
Patients and methods: Infants were randomized within 48 hours of birth to a 
NIDCAP group or basic developmental care (C) group. The NIDCAP intervention 
consisted of weekly formal behavioral observations of the infants and caregiv-
ing recommendations for the staff and parents as well as incubator covers and 
positioning aids. The C group infants were given basic developmental care which 
consisted of only incubator covers and positioning aids. Outcome measures: respi-
ratory support: days of mechanical ventilation and/or CPAP. Intensive care: days 
requiring mechanical ventilation and/or CPAP and/or weight <1000 grams. Growth 
parameters were measured (bi)weekly and at term age. Neuromotor development 
was assessed at term age by a standardized exam (Prechtl). 
Results: A total of 164 infants met inclusion criteria (NIDCAP=81, C=83).
In-hospital mortality was 8/81 (9.9%) in the NIDCAP group and 3/83 (3.6%) in the 
C group. No difference in mean days respiratory support (13.9/16.3) or mean days 
IC (15.2/17.0) were found (NIDCAP/C, respectively). Short-term growth and neuro-
motor development at term age showed no differences even when correcting for 
the duration of the intervention. 
Conclusions: NIDCAP developmental care has no effect on respiratory support, 
intensive care days or growth and neuromotor development at term age. 
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Introduction
 Advanced technology in neonatal care has resulted in increasing survival rates 
of preterm infants1-3 . This has not however led to either major improvements in 
morbidity rates or a decrease in the risk of developmental delays, physical disabili-
ties and behavioral disorders1,4,5. Developmental care programs have been used 
to support the infant and family during their stay in the Neonatal Intensive Care 
Unit (NICU) with the premise that reducing the stress the infant experiences in 
the NICU and supporting the infant’s development may have a positive impact on 
outcomes. Most research has been based on the NIDCAP (Newborn Individual-
ized Developmental Care and Assessment Program), which is a comprehensive 
approach in which caregiving is based on the individual behavior of the infant 6. A 
meta-analysis by Jacobs et al concluded that the evidence showing a positive effect 
from the NIDCAP program is inconclusive and they recommended further RCT 
studies with a larger sample size for appropriate power, long-term follow-up and 
the inclusion of cost effectiveness evaluations7.
 Between April 2000 and May 2002, our first randomized controlled trial was 
carried out comparing basic Developmental Care (incubator covers, nests and 
positioning aids) with standard care (no covers, nests or positioning aids), but no 
short-term significant effects were found8. We then wanted to explore the effects 
of a more comprehensive behavioral-based individualized developmental care 
program such as NIDCAP.
 The aim of this randomized controlled trial (RCT) was to explore the effectiveness 
of the NIDCAP individualized developmental care program on neonatal morbidity, 
neuromotor development and growth at term age of preterm infants < 32 weeks GA 
as compared to basic developmental care.
Patients and Methods
 The study was carried out at a tertiary NICU at 2 locations in the Netherlands: 
Leiden University Medical Center in Leiden and Juliana Children’s Hospital in The 
Hague. Inclusion criteria were: infants born with a gestational age < 32 (31+6) 
weeks. Exclusion criteria included: infants with major congenital anomalies, 
infants needing major surgery and infants of drug-addicted mothers. After parental 
informed consent was obtained by the resident or staff member on call, infants were 
randomized within 48 hours of birth to the NIDCAP developmental care (NIDCAP) 
group or the Control (C) group using sealed envelopes made in groups of 6 using 
a computer generated randomization allocation. According to protocol, infants in 
both groups who were admitted for less then 5 days were excluded from follow-up 
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and outcome analysis, because the duration of the intervention was hypothesized 
not to be long enough to obtain an effect. A power analysis performed before the 
study showed that a total sample size of 140 infants was needed to show a signifi-
cant difference (p level < .05) with a power of 80%; based on a difference of half 
a standard deviation on the Bayley developmental test scores at 1 and 2 years of 
age, corrected for prematurity and was deemed sufficient power for the short-term 
primary neonatal outcomes.
 In addition to providing basic developmental care such as incubator covers and 
nests and positioning aids to encourage flexion and containment, formal behavioral 
observations of the infants in the NIDCAP group were carried out within 48 hours 
of birth and then weekly thereafter by trained certified NIDCAP developmental spe-
cialists. The observation was then discussed with parents and caregivers. Formal 
observation reports were available at the infants’ bedside. Individual care plans 
based on these observations with caregiving recommendations for parents and 
staff were hanging clearly visible at the infant’s bedside. Parents were supported in 
understanding their infant’s behavior and how to approach and support their infant 
during caregiving interactions and procedures. They were also provided with photo 
booklets explaining preterm infant behavioral cues. The infants in the NIDCAP group 
were primarily cared for by nurses who had received extra training and support in 
behavioral-based individual developmental care. A NIDCAP certified developmen-
tal psychologist supervised the intervention as well as carried out observations and 
supported the parents and staff. If an infant was transferred to a regional hospital, a 
report was made with a behavioral summary and recommendations for caregiving 
for the parents. 
 Infants in the C group were given only basic developmental care which consisted 
of incubators covers and nests and positioning aids. Parents of both groups had 
regular access to a social worker for support. The Ethical Committees of both 
locations approved the study.
Definitions
 Severity of illness was analyzed using the CRIB (Clinical Risk Index for Babies) 
score which assesses initial neonatal risk. Scores are given for birth weight, ges-
tational age, maximum and minimum fraction of inspired oxygen and maximum 
base excess during the first 12 hours, and the presence of congenital malforma-
tion 9. Inborn infants were infants born in the participating tertiary neonatal center. 
The primary medical outcome variables included: duration of respiratory support, 
number of intensive care days and short-term growth. Mechanical ventilation 
(SIMV and/or HFO) and/or CPAP were measured in days. If an infant received both 
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mechanical ventilation and CPAP in one day, the method of respiratory support 
given for the most hours was chosen. In addition, the total number of days of 
respiratory support was defined as total combined days of mechanical ventilation 
and CPAP. 
 Discharge from the intensive care was based on two criteria: the infant required 
no mechanical ventilation and/or CPAP for 24 hours and weighed at least 1000 
grams. 
 Infants were weighed at least biweekly; head circumference and length were 
measured within the first 2 days of life and thereafter weekly by trained medical 
students until the infant was either transferred or discharged. Short-term growth 
(weight, head circumference, length) was defined as measurement at birth and 
at term age as well as mean daily weight gain in grams and mean weekly length 
and head circumference growth in centimeters. Weight was measured on neonatal 
pediatric digital scales, length was measured from crown to heel and head circum-
ference was measured around the largest area of the head, occipital-frontal circum-
ference (OFC), using a non-stretch tape measure. 
 Mortality was defined as early neonatal death if the infant died within the first 
7 days of life and late neonatal death if the infant died after 7 days but before 28 
days of life. In addition secondary outcomes were analyzed. Length of stay (LOS) 
was defined as total days of hospitalization in the participating hospital as well as 
the regional hospital until discharge to home. Days of oxygen were calculated as 
total days of supplementary oxygen as well as the need for oxygen after 28 days of 
life. Bronchopulmonary dysplasia (BPD) was defined as oxygen dependency at 36 
weeks postconceptional age (PCA) according to the criteria of Shennan 10.  Postnatal 
steroids were divided into 3 classifications; 7-10 days, 15-20 days or more than 20 
days (maximum dosage of 0.2 mg/kg/day, tapered off over a period of 16 days). 
Intraventricular hemorrhage (IVH) was recorded according to Volpe11.  Periventricu-
lar leukomalacia (PVL) was classified according to grades 1-412. Sepsis was based 
on a positive blood culture. Meningitis was defined as a positive cerebrospinal fluid 
(CSF) culture and/or pleocytosis. The incidence of necrotizing enterocolitis (NEC), 
persistent ductus arteriousus (PDA), retinopathy of prematurity (ROP), need for 
treatment of hypotension and hyperbilirubinemia was also analyzed. 
Follow-up
 At term age, infants were seen in the follow-up clinics to assess growth, morbidity 
and neuromotor development by neonatologists experienced in developmental 
assessments and blinded to the group assignment of the infant. A standardized 
neurological exam according to Prechtl13 was administered and was defined as 
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definitely abnormal (DA), mildly abnormal (MA) or normal. Definitely abnormal is 
defined as the presence of a full-blown neonatal neurological syndrome, such as 
apathy or hyperexcitability, hypotonia or hypertonia, hyporeflexia or hyperreflexia, 
hypokinesia or hyperkinesia, or a hemi-syndrome. Mildly abnormal denotes the 
presence of only part of such a syndrome. Examples of minor neurological signs 
are abnormal posture, abnormal head control and absent or abnormal responses 
or reflexes.
Statistical Analysis
 Data was analyzed using SPSS 14.0 for Windows. The infant and parent char-
acteristics were compared with the Chi-square test (for trend) or the two-sample 
t-test where appropriate. Outcome parameters were compared between the two 
treatment groups with the t-test, Mann-Whitney test or Chi-square test (for trend) 
where appropriate. P-values < 0.05 were considered significant. Linear regression 
was used to evaluate the influence of the duration of the intervention on term age 
outcomes by testing if there was an interaction effect between the intervention 
duration and the 2 treatment groups. Median days of CPAP, days of respiratory 
support and IC days were obtained from Kaplan-Meier curves and compared using 
the log rank test, where measurements of infants who died were censored.  
RESULTS
 In total 168 infants were originally recruited between July 2002 and November 
2004 for the study; 84 in the NIDCAP group and 84 in the C group. Four infants 
(NIDCAP: 3, C: 1) were excluded according to protocol because they were admitted 
less than 5 days or died within the first 5 days. This left a total of 164 infants that 
met inclusion criteria. Of the 164 included infants, 8/81 (9.9%) in the NIDCAP 
group and 3/83 (3.6%) in the C group died during hospitalization. The difference 
of the in-hospital mortality rate between the 2 groups was not significant (p=0.11). 
The majority of incidences of infant mortality (NIDCAP: 7/8, C: 3/3) was classified 
as late neonatal death, between 8 and 28 days of life, with the main cause of death 
being cerebral or pulmonary complications.  Seventy-three infants in the NIDCAP 
group and 80 infants in the C group were assessed at term age. Two infants in the 
C group were followed at term age in another hospital not participating in the study, 
and were classified according to a different neurological exam by their pediatri-
cian as normal and mildly abnormal respectively. These infants were not included 
in the neurological assessment outcome. Their growth parameters however were 
included in the growth analysis. The mortality rate and loss to follow up are shown 
in Figure 1. 
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 Parent characteristics for the study population were similar with no significant 
differences found and are shown in Table 1. There was no difference in infant char-
acteristics between the NIDCAP and C group (Table 2). Five infants in the NIDCAP 
group were hospitalized temporarily elsewhere for surgical or other necessary 
treatment. These infants were included in the outcome under the intention-to-treat 
protocol. 
Primary Outcomes
 There was no significant difference found in the number of Intensive care (IC) 
days, days of respiratory support or growth between the NIDCAP and C groups. 
Infants at follow-up at term age: 73 Infants at follow-up at term age: 80
Remaining infants: 73 Remaining infants: 80
8 infant deaths 3 infant deaths
81 infants included 83 infants included
1 infant excluded due to admisstion 
< 5 days
2 infant deaths < 5 days
1 infant death < 5 days
84 NIDCAP group 84 C group
168 total infants recruited
Infants in Developmental Care Study
Figure 1
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Table 1. Maternal medical and parental demographic background variables
NIDCAP
n=81   
C 
n=83
Obstetrical history
Pre-existing disease
(diabetes, hypertension, other)
 9/81 (11.1) 14/83 (16.9)
Pregnancy induction 13/81 (16.0) 14/83 (16.9)
Diseases during pregnancy 
diabetes mellitus gravidarum
(pre)eclampsia or HELLP syndrome
 2/81 (2.5) 
13/81 (16.0)
3/83     (3.6)
16/83 (19.3)
Medication during pregnancy
antihypertensives
antibiotics
tocolytics 
other
Antenatal glucocorticoids
one dose
1 course (2 doses)
14/81 (17.3)
32/81 (39.5)
45/81 (55.6)
 7/81 (8.6)
29/80 (36.3)
33/80 (41.3)
19/83 (22.9)
25/83 (30.1)
43/83 (51.8)
14/83 (16.9)
35/83 (42.2)
29/83 (34.9)
Mode of delivery
vaginal
caesarean section
41/81 (50.6)
40/81 (49.4)
45/83 (54.2)
38/83 (45.8)
PROM > 24 hours* 25/81 (30.9) 19/83 (22.9)
Primipara 54/81 (66.7) 42/83 (50.6)
Parental demographic background
Maternal age 
    mean in years, sd
Paternal age 
    mean in years, sd
n=74
30.0     (5.2)
n=72
32.3     (5.6)
n=78
31.9     (5.0)
n=77
34.1     (5.5)
Mother Caucasian
Father Caucasian
66/80 (82.5)
63/79 (79.7)
70/80 (87.5)
64/80 (80.0)
Education level mother † 
low
intermediate
high
26/72 (36.1)
25/72 (34.7)
21/72 (29.2)
19/77 (24.7)
26/77 (33.8)
32/77 (41.6)
Education level father † 
low
intermediate
high
19/69 (27.5)
22/69 (31.9)
28/69 (40.6)
15/76 (19.7)
32/76 (42.1)
29/76 (38.2)
Data shown is n (%), unless otherwise indicated
* Premature rupture of membranes
† Low = vocational training, intermediate = high school, high = college/university
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Table  2. Infant medical background variables of all participating infants
Birth Characteristics
NIDCAP 
n=81
C
n=83
Gestational age 
mean in wks, sd
range
n=81
29.3  (1.8)
24.7 – 31.9
n=83
29.2  (1.6)
25.6 - 31.6
Birthweight 
mean in g, sd
range
n=81
1215 (328)
577 - 1939
n=83
1226 (343)
625 - 2060
Length  
mean in cm, sd
range
n=81 
37.1   (3.1)
29.0 - 43.0
n=83
36.8  (3.3) 
29.0 - 44.0
Head circumference 
mean in cm, sd
range
n=81
26.8      (2.2) 
22.4 – 32.0
n=83
26.6 (2.3)
21.5 – 30.5
Male gender 46/81  (56.8) 43/83 (51.8)
SGA* P < 10 and P ≥ 3 
SGA P < 3
15/81  (18.5)
3/81      (3.7)
10/83 (12.0) 
 5/83 (6.0)
Twin 27/81  (33.3) 34/83 (41.0)
Inborn 51/81  (63.0) 49/83 (59.0)
Apgar scores at 5 minutes
      mean (sd)
      median (range)
n=80
8.1 (2.2)
8 (3- 10)
n=80
8.3 (1.4)
8 (4 - 10)
CRIB Score 
median (range)
RDS* 
grade 1
grade 2
grade 3
grade 4
Surfactant 
Hyperbilirubinemia
Days of phototherapy (mean, sd)
n=81
2 (0 – 14)
20/81 (24.7)
11/81 (13.6)
17/81 (21.0)
  6/81   (7.4)
41/81 (50.6)
73/81 (90.1) 
4.4 (2.9)
n=83
3 (0 – 13)
23/82 (28.0)
13/82 (15.9)
17/82 (20.7)
 8/82 (9.8)
39/83 (47.0)
76/83 (91.6)
4.8 (3.4)
Data shown is n (%), unless otherwise indicated
Comparisons were done using chi-square test (for linear trend) or t-tests where appropriate
* SGA: small for gestational age, RDS: respiratory distress syndrome
Chapter 5
78
Seventy-three infants 73/81 (90.1%) in the NIDCAP group and 77/83 (92.8%) 
infants in the C group required some form of respiratory support. This analysis was 
based on all included infants. We performed the same analysis of the infants who 
survived, NIDCAP: 73/81(90%), C: 80/83 (96%). The infant characteristics as well 
as the primary and secondary outcomes showed no significant differences between 
groups (data not shown).  
 All of the surviving 153 infants (NIDCAP: 73, C: 80) were assessed at term age. 
Age at follow-up assessment was comparable for both groups. There was no sig-
nificant difference found in the neurological outcomes between the NIDCAP and C 
group. Three surviving infants (NIDCAP: 2, C: 1) diagnosed with posthemorrhagic 
ventricle dilatation were excluded from the weekly and term age head circumfer-
ence analysis. There was no significant difference found between the NIDCAP and 
C group in the growth parameters at term age or in daily weight gain (g), weekly 
length and head circumference (cm) growth (Table 3).
 A linear regression analysis was carried out to analyze if the number of days 
infants received the NIDCAP intervention influenced the neuromotor outcome and 
growth at term age by testing if there was an interaction effect between the inter-
vention duration and the two treatment groups. There was no significant effect on 
the neurological outcome (p=0.72), term age head circumference (p=0.94): term 
age weight (p=0.28) or term age length (p=0.54) found.
Secondary outcomes
 The total length of stay (LOS) from birth to discharge to home or the gesta-
tional age of the infants when discharged from the hospital was not different in 
the 2 groups. There was no difference in the days of oxygen received or infants 
that required oxygen after 28 days or incidence of BPD between the two groups. In 
total 7/81 (8.6%) infants in the NIDCAP group required postnatal corticosteroids 
as opposed to 11/83 (13.3%) infants in the C group (p=0.35), with twice as many 
infants in the C group requiring corticosteroids for more than 2 weeks. There were 
significantly more infants in the NIDCAP group 25/81 (30.9%) with PDA requiring 
medication and/or surgery than in the C group 11/83 (13.3%). Of the 25 NIDCAP 
infants with PDA, 6/25 (24%) died in-hospital and 1/11 (9%) infant with PDA died 
in the C group. When we analyzed the surviving infants, the NIDCAP group 19/73 
(26%) still had twice as many infants with PDA than the C group 10/80 (12.5 %); 
p=0.03. At term age there was no difference in the incidence of PVL or the number 
of infants requiring physical therapy. There were also no significant differences 
found in the remaining secondary outcomes (Table 4). 
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Table  3. Comparison of data of primary outcome measures 
NIDCAP 
n=81
C
n=83
p value
Days of hospitalization (mean, sd)
  median (range)
41.5* (30.9)
37  (6-159)
40.4 (37.9)
30  (5-285)
0.83
Days IC (mean, sd)
  median (range)
15.2 (14.8)
9 (0-54)
17.0 (16.5)
11 (0-80)
0.46
Number of infants requiring respiratory support
    Days of mechanical ventilation** (mean, sd)
   median (range)
    Days of CPAP (mean, sd)
   median (range)
    Total days ventilatory support† (mean, sd)
   median (range)
73/81 (90.1)
5.6     (7.0)
2.0   (0-25)
8.4     (9.9)
4.0   (0-36)
13.9 (14.6)
9.0   (1-52)
77/83 (92.8)
6.4     (9.3)
2.0   (0-41)
10.0 (11.0)
6.0   (0-67)
16.3 (16.7)
10.0 (1-79)
0.54
0.60
0.35
0.35
Growth parameters at term age 
Age in weeks (mean, sd)
Weight in kg 
     mean, sd
     daily weight gain in grams (mean, sd)
Head circumference in cm ‡ 
     mean, sd
     weekly head circumference growth in cm§
Length in cm 
     mean, sd
     weekly growth in length in cm (mean, sd)
n=72
41.1   (1.9)
n=72
3.11 (0.63)
23.9   (5.8)
n=70
35.5   (1.6)
0.76 (0.14)
n=72
49.0   (2.8)
1.00 (0.22)
n=80
41.1   (2.0)
n=80
3.10 (0.57)
22.9   (5.2)
n=79
35.6   (1.5)
0.76 (0.12)
n=77
48.5   (2.9)
0.99 (0.19)
0.94
0.86
0.25
0.62
0.90
0.23
0.29
Neurological outcome at term (Prechtl)
normal
mildly abnormal
definitely abnormal
n=73
39/73 (53.4)
23/73 (31.5)
11/73 (15.1)
n=78§
40/78 (51.3)
34/78 (43.6)
 4/78 (5.1)
0.47
Data shown is n (%), unless otherwise indicated
Comparisons were done using chi-square test (for linear trend), t-tests or Mann-Whitney tests where appro-
priate
 * also indicates number of days intervention was given
** SIMV and or HFO
  † Total days SIMV, HFO and CPAP combined
  ‡  Infants with posthemorrhagic ventricle dilatation (n=2 NIDCAP, n=1 C) were excluded from head circum-
ference analysis
  § Two infants not assessed according to Prechtl
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Table  4. Comparison of data of secondary outcome measures
NIDCAP
 n=81
 C
 n=83
p value
In-hospital mortality
early neonatal death 
late neonatal death
8/81    (9.9)
1/81    (1.2)
7/81    (8.6)
3/83    (3.6)
0 
3/83    (3.6)
0.14
LOS† in days
mean (sd)
median (range)
n=70
61.9 (24.5)
57.5 (32-159)
n=74
67.6 (34.2)
58.5 (30-285)
0.24
GA† at discharge to home
mean in weeks (sd)
n=70
38.5 (2.7)
n=74
38.9 (4.4)
0.50
Total days supplemental O2  
mean (sd)
median (range)
O2 requirement > 28 days of life 
BPD † 
17.2   (22.6)
6  (0-100)
25/81 (30.9) 
12/80 (15.0)
16.4   (25.4)
3 (0-121) 
24/82 (29.3)
16/81 (19.8)
0.84
0.82
0.43
Postnatal corticosteroids 
< 7 days
7-14 days
15-20 days 
> 20 days
1/81     (1.2)
2/81     (2.5)
2/81     (2.5)
2/81     (2.5)
1/83     (1.2)
2/83     (2.4)
7/83     (8.4)
1/81     (1.2)
0.37
IVH †
grade I - II
grade III (and periventricular echodensity)
Posthemorrhagic ventricular dilatation
17/81 (21.0)
6/81     (7.4)
2/81     (2.5)
19/83 (22.9)
4/83     (4.8)
6/83     (7.2)
0.72
0.16
NEC †
Sepsis
Meningitis
PDA†  (indomethacin and/or surgery)
Dopamine/Dobutamine
ROP †
3/81     (3.7)
38/81 (46.9)
 1/81    (1.2)
25/81 (30.9)
22/81 (27.2)
8/70   (11.4)
3/83     (3.6)
45/83 (54.2)
 1/83  (1.2)
11/83 (13.3)
23/83 (27.7)
10/73 (13.7)
0.86
0.35
0.99
0.01*
0.94
0.82
PVL †   at term age follow-up 
grade 1
grade 2
grade 3
grade 4
Physical therapy required at term 
5/72     (6.9)
1/72     (1.4)
1/72     (1.4)
0
16/73 (21.9)
10/80 (12.5)
0
1/80     (1.3)
0
11/80 (13.8)
0.76
0.32
Data shown is n (%), unless otherwise indicated
Comparisons were done using chi-square test (for linear trend) or t-tests where appropriate
* p value < 0.05 was considered significant
† LOS: length of stay, BPD: bronchopulmonary dysplasia, IVH: intraventricular haemorrhage,
  NEC: necrotising enterocolitis,  PDA: patent ductus arteriosus,  ROP: retinopathy of prematurity, 
  PVL: periventricular leukomalacia
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Survivor Analysis
 Because our primary outcomes were respiratory support and IC days, we also 
wanted to include the data from the infants who died in-hospital, so we carried out 
a Kaplan Meier analysis. No differences were found in the total population (Figures 
2a-c). Because there was a significant difference in incidence of PDA between the 
groups (Table 4), we also carried out a post-hoc Kaplan Meier survival analysis and 
stratified for infants with PDA requiring medication or surgery, or infants without 
significant PDA. In the subgroup of infants with no PDA, the NIDCAP group 
required less median days of CPAP (p=0.02), total respiratory support (p=0.02) 
and total days intensive care (p=0.06) as compared to the C group (Figures 3a-b). 
 As phototherapy may influence the closure and/or reopening of a PDA we 
compared days of phototherapy but found no difference between the groups 
(NIDCAP: 4.4 mean days, C: 4.8 mean days)14. 
Discussion
 In this randomized controlled trial examining the short-term effects of the com-
prehensive NIDCAP developmental care program compared to basic developmen-
tal care on neonatal morbidity, neurological outcome and growth at term age of 
infants born < 32 weeks, we found no significant positive effects of the intervention 
on need for respiratory support or IC days. There were no differences between the 
NIDCAP and C group in growth and neurological outcomes at term age, even when 
correcting for days of intervention. 
Respiratory Support
 A Cochrane review meta-analysis found infants receiving NIDCAP had signifi-
cantly fewer ventilation days and no differences in days of oxygen, however stated 
that the results were conflicting and the studies showed much heterogeneity and 
should be reviewed with caution15. An RCT by Westrup et al of 25 infants born with 
a gestational age < 32 weeks and with the need for ventilatory support at 24 hours 
showed no significant difference in days of mechanical ventilation and a trend 
(p=0.045) in days of CPAP in favor of the NIDCAP group (NIDCAP: 43.9, C: 26.1) 
as well as a younger PCA of oxygen withdrawal16. The number of included patients 
in this study was small (E: 12, C: 13) because the trial had to be terminated earlier 
than expected. 
 Earlier NIDCAP studies by Als and Fleischer have also shown positive results 
concerning the need for ventilatory support17,18, however only infants born < 30 
GA and birth weight < 1250 grams were included and they had specific ventilation 
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Figures 2a-c. Comparison of days CPAP, ventilatory support and IC days of all participating infants
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Figures 2a-c. Comparison of days CPAP, ventilatory support and IC days of all 
                      participating infants 
706050403020100
100
80
60
40
20
0
Pe
rc
en
ta
ge
Intervention-
censored
Control-censored
Intervention
Control
Control/Intervention 
group
Kaplan Meier analysis
                     Total days CPAP 
806040200
100
80
60
40
20
0
Pe
rc
en
ta
ge
Intervention-
censored
Control-censored
Intervention
Control
Control/Intervention 
group
Kaplan Meier analysis
           Total days respiratory support 
806040200
100
80
60
40
20
0
Pe
rc
en
ta
ge
Intervention-
censored
Control-censored
Intervention
Control
Control/Intervention 
group
Kaplan Meier analysis
                     Total days IC 
Total days CPAP
Total days respiratory support
Total days IC
A Randomized Controlled Trial examining the Effects of NIDCAP
83
Figure 3a. Comparison of days of respiratory support in infants with no PDA
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Figure 3a. Comparison of days of respiratory support in infants with no PDA 
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inclusion criteria (Als: IMV within first 3 hours and IMV > 24 hours of first 48 hours 
of life; Fleisher: no IMV in first 3 hours of life or for > 24 hours in first 48 hours of 
life). A later three-center trial by Als showed no significant difference in respira-
tory support between the NIDCAP and control group but there were differences 
between sites (parental demographic and infant medical background variables)15,19. 
Our study included infants born < 32 weeks regardless of their need for ventilator 
support and had lower CRIB scores than Westrups’s study, indicating they were 
more stable in the first 12 hours of life. 
IC Days
 The three-center RCT by Als et al of 92 preterm infants with a birth weight < 1250 
grams and gestational age < 28 weeks showed significantly less days of intensive 
care in the infants receiving NIDCAP19. We were not able to duplicate those findings 
in our study, however our population was different in that we included older infants 
< 32 weeks gestational age with no restriction on birth weight. The total number 
of IC days in our study was considerably less than the above mentioned study, 
perhaps reflecting the difference in population or a different definition of IC days as 
the criteria for intensive care days was not defined in the study by Als. Wielenga et al 
found no significant difference in IC days between NIDCAP and conventional care, 
but also did not define their criteria for intensive care days20. Other NIDCAP studies 
looked at total days of hospitalization but did not report days of intensive care.
Growth
 A study by Als et al showed a significantly better average daily weight gain and 
improved growth (weight, head circumference and height) to term age in the infants 
receiving NIDCAP19. Westrup’s study showed no significant effect on growth (weight 
gain and head growth) up to 35 weeks PCA16. The Cochrane meta-analysis that did 
not include the above mentioned study by Als due to site differences concluded 
that NIDCAP did not effect growth in infants surviving to 9 months corrected age15. 
Our short-term growth results are comparable to these findings. 
Neurobehavioral outcome
 Another study by Als et al21 of 30 stable preterm infants between 28-33 weeks 
GA showed significant improvements in neurobehavioral outcomes according to 
Prechtl at 2 weeks corrected age. The Prechtl outcome was defined by 12 summary 
variables and a total score showing the percentage of abnormal scores in each 
group. Buehler’s study of stable preterm infants between 30-34 weeks GA and 
birth weight < 2500 grams showed significantly better scores in 3 of the 10 Prechtl 
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summary variable scores as well as the total score at term age in the NIDCAP 
infants as well22. We found no significant difference in our study in which neurobe-
havioral outcome according to Prechtl was defined as DA, MA or normal, so were 
not able to compare our results with theirs. 
PDA
 After randomization, our study showed significantly more infants in the NIDCAP 
group with PDA requiring medication or surgery (Table 4). The mean days of pho-
totherapy, which can influence ductal reopening were similar for both groups so 
there is no plausible reason NIDCAP group infants had significantly more PDA that 
needed treatment14. Most of the infants (NIDCAP: 17/19, C: 9/10) were given a 3-
dose course of Indomethacin which successfully closed the ductus. Two infants in 
the NIDCAP group and 2 infants in the control group were first given a course of 
Indomethacin and then treated with surgical ligation. 
 When we examined the subgroup of infants with no PDA (NIDCAP: 56, C: 72) 
using a Kaplan Meier analysis, we did find a significant difference in days of CPAP 
and total respiratory support in favor of the NIDCAP group. We assume on clinical 
grounds that most of the PDA’s were diagnosed after inclusion (within 48 hours 
after birth) into the study. So while there may be a possible benefit from NIDCAP 
for a subgroup of infants without PDA in days of respiratory support, these findings 
should be interpreted with caution. The presence of PDA did appear to influence 
neurodevelopmental outcomes, as 7/11(64%) of the NIDCAP infants with a DA 
score on the Prechtl exam at term age had PDA, and only 1/4 (25%) of the C infants 
with a DA score had PDA, reflecting the higher incidence of PDA in the NIDCAP 
group. There were also more boys (57.9% vs 30%) and SGA infants (31.6% vs 20%) 
in the NIDCAP group with PDA than the C group. 
Secondary outcomes
 Wielenga et al showed NIDCAP infants had less incidence of severe cerebral 
damage23 in a phase-lag study of infants born < 30 weeks gestation in which 26 
infants received conventional treatment and after 6 months training, 25 infants 
received NIDCAP developmental care. There were significant differences in the 
neonatal background characteristics between the two groups in that the NIDCAP 
infants were smaller and had less multiples than the conventional care group and 
the NIDCAP infants developed significantly more pneumonia, possibly due to an 
outbreak of a nosocomial infection in the NICU during the NIDCAP implementa-
tion. One advantage of a phase-lag study is the ability to implement a program 
such as NIDCAP throughout the entire department; however the disadvantage of 
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having different periods of research in which there may be changes in the depart-
ment may affect results. Therefore they have stated that these results should be 
interpreted with caution23.
 The Cochrane meta-analysis of 3 studies17,21,24 showed no evidence that NIDCAP 
affected the incidence of IVH, grade 3 or 415, nor was there a significant difference 
in either the Swedish trial16 or the 3-center trial19. Our study was comparable in that 
there were no differences in outcomes of IVH and or PVL between groups found.
 In addition, a significant effect of NIDCAP was found on moderate-severe chronic 
lung disease according to the Cochrane review15. In this study, despite the fact that 
the C group required more postnatal corticosteroids than the NIDCAP group, there 
was no difference in the incidence of BPD.    
 The total days of intervention were less when compared to previous NIDCAP 
trials, which is a limitation of our study as this would impact the amount of days 
NIDCAP developmental care would be given. If we compare the number of intensive 
care days as well as the total days of hospitalization, the infants in our study required 
less days of intensive care and were transferred to regional hospitals earlier, so that 
the amount of days of the intervention was, with a percentage of our participating 
infants, less than in previously reported studies. Because of the regionalization of 
neonatal intensive care in the Dutch neonatal health care system, infants often are 
transferred to regional hospitals who can provide post-IC and intermediate care. 
There were 33/80 (41%) of the surviving C group and 37/73 (51%) of the surviving 
NIDCAP group infants who remained in the participating hospitals for at least 6 
weeks. Because of this variation we did correct for amount of days of the interven-
tion, but this did not change the term age outcomes. 
 This study is to our knowledge the largest RCT examining the effects of NIDCAP 
developmental care on preterm infants. All but 2 of the surviving 153 infants were 
seen at follow-up at term age. The infants were randomized in an appropriate 
manner; however there could be no blinding of the intervention as all infants were 
cared for in the same intensive care unit and the NIDCAP infants had recommen-
dations for caregiving at their bedside. The amount of respiratory support given to 
an infant was decided upon by several neonatologists and was not influenced by 
the study group the infant participated in. Since the discharge from the intensive 
care was based on two criteria: the infant required no mechanical ventilation and/
or CPAP for 24 hours and weighed at least 1000 grams, IC days could also not be 
influenced by group participation. In addition, the follow-up at term age was carried 
out by neonatologists blinded to the participation group. 
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 Despite the large sample size compared to previous NIDCAP studies and well 
defined outcome measurements, we were not able to find any significant differ-
ences in our primary outcomes. In a previous study examining the effects of basic 
developmental care compared to controls8, we also did not find any significant 
effects of the intervention in short-term outcomes to term age.
 Future research in NIDCAP should include not only the neonatal intensive 
care centers but the regional hospitals where infants are transferred to as well. In 
addition, an intervention program where infants and parents are supported after 
discharge may help to improve outcomes, as it would provide a continuation of the 
support already given to infants and families in the hospital. 
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Abstract
Objective: Randomized controlled trial investigating the effect of NIDCAP develop-
mental care on growth, cognitive, psychomotor and neuromotor development in 
infants born < 32 weeks.
Methods: Infants were randomized within 48 hours of birth to the NIDCAP group 
or basic developmental care C group (incubator covers or nests). At 1 and 2 years 
corrected age (CA) growth was measured and standardized neurological exams 
were administered. Mental (MDI) and psychomotor (PDI) development was 
assessed using the Dutch version of the Bayley Scales of Infant Development II. To 
obtain a total outcome measure, neurological outcome, PDI and MDI scores were 
combined.
Results: 168 infants were recruited (NIDCAP: 84; C: 84). Four infants (NIDCAP: 3, 
C: 1) were excluded because they were admitted less than or died within the first 5 
days, leaving a total of 164 infants that met inclusion criteria. In-hospital mortality 
was 8/81 (9.9%) in the NIDCAP group and 3/83 (3.6%) in the C group. At one year 
148 children (NIDCAP: 70, C: 78) and at 2 years 146 children (NIDCAP: 68, C: 78) 
were assessed. There was no significant difference in growth at 1 and 2 years. There 
was no significant difference in neurological outcome or mental and psychomotor 
development at 1 and 2 years found. When neurological outcome, MDI and PDI 
scores were combined, there still remained no significant difference. 
Conclusions: NIDCAP developmental care showed no effect on growth, neurologi-
cal, mental and psychomotor development at 1 and 2 years in infants born < 32 
weeks. Duration of the NIDCAP intervention was not associated with neurological 
and developmental outcome. 
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Introduction
 Advances in the care of preterm infants have increased their survival rates, but 
the chance of later developmental and/or behavioral problems remains high for a 
considerable percentage of these infants and may continue into young adulthood1-
3. Cerebral palsy rates have not fallen over the past 10 years although survival has 
improved and increasing survival at low gestations is associated with the highest 
prevalence of cerebral palsy4. The most common disability at two years is develop-
mental or cognitive impairment, which assumes greater significance in the school 
years.  Cognitive differences between ex-preterm infants and term born infants show 
a greater need for educational support and higher prevalence of school problems in 
children without severe disabilities5. In addition, VLBW children have an increased 
risk of developing attention deficit hyperactivity disorders (ADHD), generalized 
anxiety and symptomatic depression6. 
 With the increasing technological advances has come the awareness that the 
intensive care and interventions used may also play a part in developmental dis-
abilities. Developmental care programs have focused on changing the environment 
and caregiving of the preterm infant while providing these necessary life saving 
interventions. The philosophy behind developmental care is that by reducing stress 
and supporting the infants’ developmental in the NICU, this in turn may impact 
their later developmental outcome. The most comprehensive and well known 
program is the Newborn Individualized Developmental Care and Assessment 
Program (NIDCAP) developed by Als, an individual approach in which caregiving 
is based on the infant’s behavior 7-9. Follow-up studies of the effectiveness of the 
NIDCAP developmental care program have shown conflicting results and are based 
on trials with a small sample size 10-15. A Cochrane meta analysis has therefore rec-
ommended conducting larger trials with more follow-up15.
 The aim of this randomized controlled trial (RCT) was to explore the effectiveness 
of the implementation of the comprehensive NIDCAP developmental care program 
on growth, mental and psychomotor development and neurological outcome at 
1 and 2 years CA of preterm infants born < 32 weeks gestational age. We hypoth-
esized that an individual developmental care approach, in which the caregiving 
during their NICU stay was guided by the behavior of the infant, would reduce 
stress and promote physiological stability and in turn would positively affect their 
later growth and development.  
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Patients and Methods
 The study was carried out from July 2002 to November 2006 at a tertiary NICU 
at 2 locations in the Netherlands: Leiden University Medical Center in Leiden and 
Juliana Children’s Hospital in The Hague. The inclusion period was from July 
2002 to August 2004 and the 1 and 2 year follow-up was from September 2003 
to November 2006. Inclusion criteria were: infants born with a gestational age 
< 32 completed weeks. Exclusion criteria included: infants with major congenital 
anomalies, infants needing major surgery and infants of drug-addicted mothers. 
After parental informed consent was obtained by the resident or staff member on 
call, infants were randomized within 48 hours of birth to the NIDCAP developmen-
tal care (NIDCAP) group or the Control (C) group (basic developmental care) using 
sealed envelopes made in groups of 6 using a computer generated randomization 
allocation. According to protocol, infants in both groups who were admitted for 
less then 5 days were excluded from follow-up because the duration of the NIDCAP 
intervention was hypothesized not to be long enough to obtain an effect. A power 
analysis performed before the study showed that a sample size of 140 infants was 
needed to show a significant difference (p value < .05) with a power of 80%, based 
on the expected difference of half a standard deviation (7.5) on the developmental 
test scores at 1 and 2 years of age. 
 The NIDCAP intervention consisted of weekly behavioral observations of the 
infants by trained certified NIDCAP developmental specialists, with the first obser-
vation being done within 48 hours of birth. Individual care plans based on these 
observations with caregiving recommendations were discussed with parents and 
caregivers and were available at the infant’s bedside. Parents were supported in 
understanding their infant’s behavior and how to approach and support their infant 
during caregiving interactions and procedures. The infants in the NIDCAP group 
were primarily cared for by nurses who had received extra training and support in 
behavioral-based individual developmental care. If an infant was transferred to a 
regional hospital, a report was made with a behavioral summary and recommen-
dations for caregiving for the parents. In addition, incubator covers and nests and 
positioning aids were provided to encourage flexion and containment. A NIDCAP 
certified developmental psychologist supervised the intervention, carried out 
observations and supported the parents and staff. The C group consisted of basic 
developmental care which included the use of incubator covers and nests and posi-
tioning aids to encourage flexion and containment. The Ethical Committees of both 
locations approved the study.
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Measures
 Infant characteristics (gestational age, birth weight, gender, small for gestational 
age, inborn, Apgar scores, CRIB score) and parental characteristics (age, ethnicity, 
educational level) were collected to compare groups (Tables 1 and 2). Severity of 
illness was analyzed using the CRIB (Clinical Risk Index for Babies) score which 
assesses initial neonatal risk. Scores are given for birth weight, gestational age, 
maximum and minimum fraction of inspired oxygen and maximum base excess 
during the first 12 hours, and the presence of congenital malformation 16. 
Follow-Up
 Children were assessed at 1 and 2 years of corrected age for prematurity (CA) 
for growth and neurodevelopment by neonatologists experienced in developmen-
tal assessments and blinded to the group assignment of the child. All mention of 
age hereafter is corrected age for prematurity. A standardized neurological exam 
according to Touwen 17,18 at one year and Hempel 19 at two years was administered 
and classified as definitely abnormal (DA) when there was definite neurological 
dysfunction such as cerebral palsy; mildly abnormal (MA) in the presence of mild 
deviations in muscle tone regulation, reflexes, fine or gross motor performance or 
cranial nerve function; or normal (N). 
 Weight was measured on a pediatric digital scale, length was measured from 
crown to heel on a standard measurement board and head circumference was 
measured around the largest area of the head, occipital-frontal circumference 
(OFC), using a non-stretch tape measure. 
 In addition, children were assessed at 1 and 2 years by psychology interns super-
vised by a clinical psychologist, who were blinded as to whether the child was in the 
NIDCAP or C group. Mental and psychomotor development was assessed using 
the Dutch version of the Bayley Scales of Infant Development II (BSID-II)20,21. The 
mean score of the mental developmental index (MDI) and the psychomotor devel-
opmental index (PDI) is 100, with 1 standard deviation (SD) of 15 points. An MDI 
or PDI ≥ 85 (≥ - 1 SD) is considered normal, an MDI or PDI between 70 and 84 (–2 
to –1 SD) is considered mildly delayed and Index scores ≤ 69 (< - 2 SD) severely 
delayed. The Dutch norms, which had become available during our research, were 
used. To obtain a single outcome measure, neurological outcome, PDI and MDI 
were combined. When at least 1 of these 3 outcome measures was DA, children 
were considered DA, and when at least 1 outcome was MA, children were consid-
ered MA.
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Statistical Analysis
 Data was analyzed using SPSS 12.0 for Windows. The infant and parent char-
acteristics were compared with the Chi-square test, the Chi-square test for trend 
or the two-sample t-test, where appropriate. Outcome parameters were compared 
between the two treatment groups with the t-test, Mann-Whitney test or Chi-square 
test where appropriate. P-values < 0.05 were considered significant. Linear regres-
sion was used to evaluate the influence of the duration of the intervention on 1 
and 2 year outcomes by testing if there was an interaction effect between the inter-
vention duration and the 2 treatment groups. Linear regression was also used to 
evaluate the influence of postnatal steroids on growth outcomes at 1 and 2 years. 
Results
 In total 168 infants were recruited for the study; 84 in the NIDCAP group and 84 
in the C group. Four infants (NIDCAP: 3, C: 1) were excluded according to protocol 
because they were admitted less than 5 days or died within the first 5 days. This left 
a total of 164 infants that met inclusion criteria. Of the 164 included infants, 8/81 
(9.9%) in the NIDCAP group and 3/83 (3.6%) in the C group died during hospital-
ization, with the main cause of death being cerebral or pulmonary complications. 
There was no significant difference in the in-hospital mortality rate between the 
NIDCAP and C group (p=0.11). This left 156 infants (NIDCAP: 73, C: 80) for follow-
up. At 1 year 148 [NIDCAP: 70/73 (95.9%), C: 78/80 (97.5%)] and at 2 years 146 
children [NIDCAP: 68/73 (93.2%), C: 78/80 (97.5%)] were seen at the follow-up 
clinic out of a total of 153 surviving infants. At 1 year, 2 infants were lost to follow-up 
and the parents of 1 infant no longer wanted to participate in the NIDCAP group 
and 2 infants in the C group were lost to follow-up. Between the 1 and 2 year assess-
ment two children in the NIDCAP group were lost to follow-up. There was no loss 
to follow-up in the C group at 2 years. The mortality rate and loss to follow-up are 
shown in Figure 1.
 There was no significant difference in the primary infant characteristics between 
the NIDCAP and C groups. Despite randomization, there were significantly more 
surviving infants with PDA requiring medication or medication and ligation in the 
NIDCAP group, p=0.03 at 1 year and p=0.02 at 2 years (Table 1). Parent character-
istics (age, ethnicity and educational level) were similar in both groups and are 
shown in Table 2. 
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2 infants lost to f/up
1 infant parents will not participate 
   in follow-up
1 infant lost to f/up
1 infant did not come back to f/up
   (major congenital anomaly)
Remaining infants: 73 Remaining infants: 80
8 infant deaths 3 infant deaths
81 infants included 83 infants included
1 infant excluded due to admission 
   < 5 days
- 6 infant deaths < 5 days
1 infant death < 5 days
84 NIDCAP group 84 C group
192 infants recruited
Infants in NIDCAP Study
2 children lost to f/up 0 child lost to f/up
70 children at 1 year f/up
70 children growth data
70 neurological exam
69 Bayley II  (1 unable to test)
78 children at 1 year f/up
78 children growth data
78 neurological exam
78 Bayley II
Infants at follow-up at term age: 73 Infants at follow-up at term age: 80
68 infants at 2 year f/up
66 children growth data
66 neurological exam (2 unable to test)
64 Bayley II (4 unable to test)
78 children at 2 year f/up
78 children growth data
75 neurological exam (3 unable to test)
76 Bayley II (2 unable to test)
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Growth
 There was no significant difference between the NIDCAP and C group in growth 
(weight in kilograms, height and head circumference in centimeters) at 1 or 2 years. 
When we calculated the SDS using the Dutch growth charts23, there was again no 
difference between the 2 groups. As postnatal corticosteroids may influence growth, 
we corrected for days of postnatal steroids and then found no significant difference 
in growth SDS between the 2 groups (Table 3). 
Table 1. Infant medical background variables of children seen at 1 and 2 year follow-up 
NIDCAP
n (%)
C
n (%)
NIDCAP
n (%)
C
n (%)
 1 year  2 years
Birth Characteristics n=70 n=78 n=68 n=78
Gestational age mean in
 wks (sd )
      range
29.6 (1.5)
25.9-31.9
29.3 (1.6)
25.6-31.6
29.6 (1.6)
25.9-31.9
29.3 (1.6)
25.6-31.6
Birthweight mean in g, (sd) 
      range
1263 (311)
(655-1939)
1247 (340)
(625-2060)
1260.8 (314.3)
(655-1939)
1246.6 (339.6)
(625-2060)
Male gender 41/70 (58.6)  40/78 (51.3) 41/68 (60.3)  40/78 (51.3)
SGA*
      SGA P* < 10 and P ≥ 3
      SGA P < 3
13/70 (18.6)
 2/70  (2.9)
10/78 (12.8) 
  4/78 (5.1)     
13/68 (19.1)
  2/68 (2.9)
10/78 (12.8) 
  4/78 (5.1)     
Inborn 44/70 (62.9) 47/78 (60.3)  44/68 (64.7) 47/78 (60.3)  
Apgar scores at 5 minutes 
     median (range)
   
9.0 (4-10) 8.0 (4-10)
  
8.0 (4-10) 8.0 (4-10)
CRIB Score mean (sd)*
    Range
PDA*  (indomethacin 
   and/or surgery)
2.7 (2.9)
0-14
19/70 (27.1)
2.9 (2.9)
0-13
10/78 (12.8) ‡
2.7 (2.9)
0-15
19/68 (27.9)
2.9 (3.0)
0-13
10/78 (12.8) †
Data shown is n (%), unless otherwise indicated
Comparisons were done using chi-square test or t-tests where appropriate
*  SGA: small for gestational age, P: percentile, CRIB: Clinical Risk Index for Babies, PDA: patent ductus 
arteriosus
†   p value 0.03 at 1 year and 0.02 at 2 years; p value significance = < 0.05
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Table 3. Growth outcomes at 1 and 2 years CA
1 year CA 2 years CA
Growth outcomes NIDCAP C p value NIDCAP C p value
Weight 
  mean in kg, sd
n=70
9.26 (1.14)
n=78
9.44 (1.45) 0.40
n=63*
12.0 (1.3)
n=78
12.3 (2.1) 0.32
  SDS† (mean, sd) -0.74 (1.10) -0.59 (1.31) 0.43 -0.64 (0.98) -0.48 (1.41) 0.42
Head circumference 
  mean in cm, sd
n=70
46.3 (1.9)
n=77
46.7 (1.8) 0.23
n=66
48.7 (1.6)
n=77*
49.0 (1.9) 0.32
  SDS† (mean, sd) -0.26 (1.21) 0.05 (1.20) 0.13 -0.07 (0.94) 0.18 (1.18) 0.15
Length 
  mean in cm, sd
n=70
75.2 (2.4)
n=78
75.1 (3.4) 0.82
n=64*
87.9 (3.3)
n=78
87.3 (4.1) 0.33
  SDS† (mean, sd) -0.33 (0.90) -0.37 (1.23) 0.81 -0.19 (1.03) -0.37 (1.19) 0.32
Comparisons were done using t-tests
* Correct n is shown in table if there are missing values 
† SDS (standard deviation scores) according to Fredriks et al 200023   
Table  2. Parental demographic background variables 
NIDCAP
n (%)
C
n (%)
NIDCAP
n (%)
C
n (%)
1 year follow-up 2 year follow-up
Maternal age 
      mean in years (sd)
n=69
31.3 (5.2)
n=75
32.9 (5.1)
n=68*
32.3 (5.3)
n=75*
33.9 (5.1)
Paternal age
      mean in years (sd)
n=67
33.5 (5.7)
n=74
35.0 (5.6)
n=66
34.4 (5.6)
n=74
36.0 (5.6)
Mother Caucasian
Father Caucasian
55/69 (79.7)
52/68 (76.5)
65/74 (87.8)
58/74 (78.4)
54/68 (79.4)
51/67 (76.1)
65/74 (87.8)
58/74 (78.4)
Education level mother †
      low
      intermediate
      high
23/67 (34.3)
23/67 (34.3)
21/67 (31.3)
19/74 (25.7)
25/74 (33.8)
30/74 (40.5)
22/66 (45.1)
23/66 (32.4)
21/66 (22.5)
19/74 (25.7)
25/74 (33.8)
30/74 (40.5)
Education level father †
      low
      intermediate
      high
16/64 (25.0)
21/64 (32.8)
27/64 (42.2)
15/73 (20.5)
31/73 (42.5)
27/73 (37.0)
15/63 (23.8)
21/63 (33.3)
27/63 (42.9)
15/73 (20.5)
31/73 (42.5)
27/73 (37.0)
Data shown is n (%), unless otherwise indicated 
Comparisons were done using chi-square test (for linear trend) or t-tests where appropriate
* Correct n is shown in table if there are missing values
† Low = vocational training, intermediate = high school, high = college/university
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Developmental outcomes
 At one year of age 147 (NIDCAP: 69, C: 78) of the 148 children seen at follow-up 
and at 2 years of age 140 (NIDCAP: 64, C: 76) of the 146 children seen at follow-up 
were tested with the Bayley Scales-II-NL. There was no significant difference in the 
mean age of all children assessed at the 1 and 2 year follow-up. We were not able 
to obtain developmental scores at 1 year of age for one child in the NIDCAP group 
and at 2 years of age for 5 children in the NIDCAP group and 2 children in the C 
group because they were uncooperative. There was no difference in developmental 
outcomes at 1 and 2 years between the two groups (Table 4). 
Neurological Outcomes and combined scores
 There were 148 (NIDCAP: 70, C: 78) children assessed with a neurological exam at 
1 year and 141 (NIDCAP: 66, C: 75) children at 2 years. Five children (NIDCAP: 2, C: 
3) could not be tested at 2 years because they were uncooperative. There was no sig-
nificant difference between the NIDCAP and C group in neuromotor development at 
1 and 2 years or in the combined developmental and neurological scores (Table 5). 
Table 5.  Neurological outcomes and combined score of neurological outcomes, MDI and PDI at 
1 and 2 years CA
1 year CA 2 years CA
NIDCAP
n  (%)
C
n  (%)
NIDCAP
n  (%)
C
n  (%)
Neurological Outcome* Neurological Outcome*
n=70 n=78 p value n=66 n=75 p value
- N†
- MA
- DA
52 (74.3)
12 (17.1)
6 (8.6)
53 (67.9)
19 (24.4)
6 (7.7)
0.60 - N
- MA
- DA
52 (78.8)
 5   (7.6)
9 (13.6)
54 (72.0)
16 (21.3)
5 (6.7)
0.99
Combined neurological 
score 
MDI and PDI
Combined neurological 
score
MDI and PDI‡
n=70 n=78 n=68 n=71
- N†
- MA
- DA
44 (62.9)
14 (20.0)
12 (17.1)
44 (56.4)
23 (29.5)
11 (14.1)
0.78 - N
- MA
- DA
34 (50.0)
21 (30.9)
13 (19.1)
37 (47.4)
31 (39.7)
10 (12.8)
0.76
Comparisons were done using chi-square test (for linear trend) where appropriate
* neurological exam according to Touwen at 1 year and Hempel at 2 years
† N=normal, MA=mildly abnormal, DA=definitely abnormal 
‡ one child from DC group and 2 children from C group’s combined scores were derived from the PDI and 
  MDI 
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 Because there was a wide range in length of stay in the participating hospitals, we 
carried out a linear regression analysis to see if the number of days infants received 
the NIDCAP intervention influenced the neurological outcome at 1 and 2 years by 
testing if there was an interaction effect between the intervention duration and the 
2 treatment groups. We found no significant effect on neurological outcome at 1 
year (p=0.97) or 2 years (p=0.30) of age or on the combined neurological and devel-
opmental scores at 1 (p=0.27) and 2 years (p=0.73). 
Discussion
 In this study examining the effects of NIDCAP compared to basic developmental 
care on infants born < 32 weeks GA, we have been unable to show any differences in 
growth, neurological and developmental outcomes at 1 and 2 years of age. The per-
centage of lost to follow-up in this large RCT was low. The assessors were blinded 
to the treatment group the children participated in and the neurological outcome 
was assessed using a standardized neurological examination. 
 Few studies have examined short-term neurodevelopmental outcomes of 
NIDCAP and the results of these studies are conflicting15. Three studies by Als et al 
showed an effect of NIDCAP on Bayley Developmental Index scores up to 9 months 
of age. The first study examined the effect of NIDCAP on 16 (E: 8, C: 8) infants born 
< 28 weeks GA with a birth weight < 1250 grams and found a significant difference 
in PDI and MDI scores at 3, 6 and 9 months in favor of the NIDCAP group as 
compared to the control group10.  A second study of 38 infants weighing less than 
1250 grams and born < 30 weeks GA also showed improved PDI and MDI scores 
at 9 months in the NIDCAP group24.  The most recent study of 30 low-risk preterm 
infants born between 28-33 weeks GA showed significantly better PDI and MDI 
developmental scores in the NIDCAP group at 9 months, however only 24 of the 
30 infants returned to follow-up at 9 months14.  These studies have not reported 
follow-up beyond 9 months of age so it is difficult to compare our results.  
 A few studies report follow-up at and beyond 1 year of age. Ariagno et al reported 
no difference at 1 and 2 years in the Bayley scores between the NIDCAP and control 
group, however there was a large loss to follow-up, as only 23 of the original 35 
infants in the study were tested13. Kleberg et al showed higher MDI scores in 9 
infants who received NIDCAP care as compared to 11 control infants at 12 months; 
however the PDI scores were not significantly different11. This study was based on 
an RCT of 25 infants born < 32 weeks with a need for ventilatory support 24 hours 
after birth25.  A second follow-up study at 3 years of age based on a non-random-
ized, historical design trial of 42 infants showed no difference in the developmen-
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tal quotients (DQ) according to the Griffiths Developmental Scale between the 
NIDCAP and control group. They did show a significant difference in mother-child 
interaction during videotaped structured and free play12. The preschool outcome 
of the RCT by Westrup showed no difference in cognition, but a possible positive 
impact of NIDCAP on behavior and is the only RCT to date to have published longer 
follow-up data26. They did state that because the recruitment was less than half of 
the anticipated subjects, their conclusions should be interpreted with caution26. All 
the above mentioned studies had relatively small sample sizes. 
 Another approach recommended would be to use qualitative research and bench-
marking as well as RCT’s, so that not only medical and developmental outcomes will 
be assessed but also additional information concerning the experience of parents 
and infants as well as staff when implementing a developmental care program27. 
Previous studies as well as our study have reported that parents and the nursing 
team were positive about the NIDCAP approach and felt that it contributed to the 
wellbeing of the infant 28-31.
 There are a few factors to take into account in our study. The length of stay of 
the infants in this trial differed widely with previous NIDCAP studies as a result of 
the Dutch system to transfer infants to regional hospitals once stabilized. Because 
of this range of days of hospitalization, we examined if the number of days infants 
had received NIDCAP care influenced neurological and developmental outcomes 
at 1 and 2 years, but found no interaction effect between length of intervention and 
follow-up outcome.
 Another consideration is the significantly higher incidence of PDA requiring 
medication or medication and ligation in the infants in the NIDCAP group. When 
we corrected for incidence of PDA, we found no significant difference in either 1 
year neurological outcome (p=0.71) and combined scores (p=0.89) or 2 year neu-
rological outcome (p=0.98) and combined scores (p=0.67).
 We conclude that providing NIDCAP to preterm infants born < 32 weeks 
gestation in a system with regionalized NICU’s and early transfer to local hospitals 
has no effect on their neurodevelopment or growth at 1 and 2 years of age. Perhaps 
follow-up studies at school age may be able to detect more subtle differences in 
cognition.
 We had hoped that by providing parents with the tools to understand their 
infant’s behavior and how to provide support, they would have been able to continue 
providing this individual approach when interacting with their infant once trans-
ferred out of the NICU, which would then have a continuing effect on their infant. It 
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appears, based on our results, that both infants and parents require longer periods 
of ongoing support in order to show any effect. 
 Recommendations for further research would be to continue the NIDCAP 
approach in the regional hospitals once infants are transferred to see if the effect 
would be greater. This however was beyond the scope of our present study. In 
addition, early intervention programs in which parents are supported once their 
infant is discharged home may help to build on the support and knowledge parents 
have received in the NICU and guide them in responding to their infants quickly 
changing developmental needs.
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 In this thesis we evaluated the effect of basic developmental care and the com-
prehensive NIDCAP developmental care program in preterm infants < 32 weeks 
gestational age born between April 2000 and August 2004 on short-term morbidity, 
growth and neurodevelopment at term age, as well as growth and neurodevelop-
ment at 1 and 2 years corrected age. 
Pilot study
 We started with a pilot study in 1999 of a short-term, hospital based intervention 
with parents of preterm infants < 32 weeks in the NICU with the goal of positively 
influencing parental knowledge and responsiveness to premature infant signals 
and behavioral cues. This was a phase-lag study in which the control group parents 
were first included. They completed a questionnaire concerning confidence in care-
giving when their child was 1 week old and again 2 weeks later. Once the inclusion 
of the control group parents was completed we began to include parents in the 
intervention group. Starting after the first week of their infant’s birth, parents were 
given 4 lessons over a period of 2 weeks concerning preterm infant behavior with 
the emphasis on understanding their own infant’s behavior. They were asked to 
complete questionnaires on knowledge of preterm infant behavior and also confi-
dence in caregiving before and at the end of the intervention. The study showed that 
the instructions significantly increased their knowledge of preterm infant behavior, 
and while their level of confidence in caregiving improved, the difference was not 
significant. There was no improvement in confidence in caregiving found in the 
control group parents. Very few fathers in the intervention group completed the 
lessons and questionnaires, and even though mothers claimed to share what they 
had learned with their spouse, this “transferring” of knowledge was not measurable 
because most fathers did not complete the questionnaires after week 3. Interviews 
of parents after the intervention indicated that they appreciated having the lessons 
and being able to better understand their infant’s behavior, as well as the support 
provided by a developmental specialist. Parents in the control group expressed the 
need for more knowledge of preterm infant behavior.
 While this was a small study with only 10 sets of parents and 22 infants, it did 
indicate that it is feasible to start an intervention program with parents early on in 
the NICU period. The pilot study also raised the level of interest in developmental 
care in the neonatal team. We concluded that a longer, more intensive program 
with a larger sample size and finding ways of incorporating more participation from 
fathers was necessary.
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Randomized Controlled Trial: Phase 1
 In Phase 1, we examined the effect of basic developmental care, which we defined 
as the use of standardized incubator covers and nests and positioning aids, on short 
and long-term outcomes up to 2 years of age corrected for prematurity. We hypoth-
esized that by providing protection from the environment with incubator covers and 
boundaries through the use of nesting, we would decrease the infants’ stress and 
physiological instability, which would result in positive short-term outcomes. There 
was a wide range of the number of days infants spent in the participating NICU, 
which reflected days of intervention given. We hypothesized that infants receiving 
basic developmental care for a longer period would show better results in term age 
outcomes. However, we found no effect on short-term morbidity, growth or neuro-
logical outcomes up to term age, even when we corrected for length of stay. 
 We were able to report that there were no detrimental effects of basic develop-
mental care, which was a concern of the neonatal staff when we first proposed this 
trial, as the use of incubator covers and nests for infants was a new concept. At that 
time, it was felt that perhaps it would be more difficult to observe the infants and 
that having an infant lie in a softly flexed position might alter the effect of ventila-
tion. In fact, the intervention infants required less days of ventilation and oxygen 
although this difference was not significant. In addition two secondary outcomes 
(postnatal steroids and requiring oxygen after 28 days of life) while not reaching the 
level of significance, suggested that there may be an advantage of developmental 
care on pulmonary morbidity. 
 We did find a positive effect on psychomotor development (PDI) at 1 year CA, but 
this improvement did not continue at 2 years and we found no significant effect on 
mental development (MDI) at 1 and 2 years CA.  We also found more infants in the 
control group with definitely abnormal neurological outcome, but since it was not 
statistically significant we could only conclude that developmental care may have a 
positive influence on neurological outcome at 1 and 2 years. 
 
 We could find no other study examining basic developmental care on neurodevel-
opment, so were unable to compare our results with other studies. Our findings did 
provide an answer to the question of whether a basic developmental care program, 
which does not entail major funding to implement, has an effect on development. 
We concluded that while it did have a positive effect on psychomotor development 
at 1 year of age, these effects did not continue up to 2 years of age.
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Randomized Controlled Trial: Phase 2
 In Phase 2, we examined the effect of the comprehensive NIDCAP program on 
short and long-term outcomes up to 2 years of age corrected for prematurity. This 
consisted of formal behavioral observations of the infant, individual care plans 
based on these observations and support to the parents in understanding and 
responding to their child’s behavior. After inclusion in phase 1 was completed and 
before starting inclusion of infants into phase 2, we spent 2 months providing extra 
lessons to a team of nurses that would be primarily caring for the NIDCAP infants. 
This was done to try to prevent as much contamination of the control group as 
possible. There were 5 nurses in the group who were completing NIDCAP training 
and who became certified and were able to assist under guidance from the develop-
mental psychologist in carrying out NIDCAP observations and supporting the care 
team, infants and parents.
 Because we only found a transient significant positive effect of basic develop-
mental care on psychomotor development at 1 year of age, we hypothesized that a 
more intensive, individualized developmental care program such as the NIDCAP 
program would show more improvement. This however was not the case and in 
fact the developmental outcomes and growth at 1 and 2 years CA did not much 
differ from the outcomes obtained in the first RCT, with the exception of the drop in 
PDI between 1 and 2 years of age in the phase 2 children.
 There were significantly more infants in the NIDCAP group with PDA requiring 
medication or medication and surgical ligation. This was unexpected as the infants 
were randomized precisely in the same manner as in phase 1. As PDA usually 
develops in the first days of life we did not feel that the intervention played a sig-
nificant role in the incidence of PDA, but realized that it could affect some of our 
short-term primary outcomes. There was no difference in days of phototherapy 
between the 2 groups, so that could not have affected the incidence of PDA. When 
we carried out a Kaplan Meier analysis we did indeed find that PDA had negatively 
affected the respiratory outcomes of the NIDCAP infants as after the analysis they 
required significantly less days (expressed in median) of CPAP and total ventilatory 
support as compared to the control infants.
 We found no positive effects at 1 and 2 years of age on mental or psychomo-
tor development or neurological outcomes in the NIDCAP group as compared to 
the control group. While the difference in developmental scores between the two 
groups was not significant, both groups’ mean PDI scores were lower at 2 years 
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when compared to the 1 year PDI and the NIDCAP group was more than a half 
standard deviation lower. It should be noted that even with this drop all the mean 
PDI and MDI scores of both groups were classified in the normal range of develop-
ment. The neurological outcomes were comparable at 1 year of age, but at 2 years 
of age, the NIDCAP group had a higher percentage of children with scores defined 
as definitely abnormal, however this difference was not significant. 
 Because of these outcomes, we concluded that NIDCAP had no effect on neuro-
logical outcome or development at 1 and 2 years of age. In addition, we found no 
effect on growth at 1 and 2 years of age. 
Behavior at 1 year of age
 In questionnaires completed by parents when children were 1 year of corrected 
age, children in the basic developmental care group had significantly higher behavior 
scores on the total competence domain and the competence subscale mastery 
motivation of the Infant–Toddler Social and Emotional Assessment (ITSEA) ques-
tionnaire, meaning that the children showed more curiosity, persistence, obedience 
and enjoyment with small accomplishments. No significant effects were found on 
problem behavior or parenting stress. We concluded that introducing a basic form 
of developmental care in the neonatal intensive care unit has a positive influence 
on the child’s competence behavior at 1 year of age1.
 When parents completed questionnaires concerning their child’s behavior and 
temperament at 1 year corrected age, the children in the NIDCAP group tended 
to show more social relatedness behavior than the children in the control group, 
especially when their length of admission was more than 1.5 months, which would 
reflect how long the NIDCAP intervention was given. In addition parents in the 
NIDCAP group reported more positive experiences and effects on the well-being of 
their infant during admission2. Further research when the children are school age 
will show if these effects remain.
Comparison to previous NIDCAP studies
 We were not able to duplicate the findings of previous NIDCAP studies even 
with our large sample size. When we compared our Phase 2 RCT to other NIDCAP 
development care studies, our total days of intensive care for both groups was 
much less, which could be due to a difference in the population and care provided, 
or simply a difference in their definition of intensive care3-6. Days of intensive care 
were also less when we compared our outcome with a study from another NICU in 
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the Netherlands, however they did not provide a clear definition or criteria for days 
of intensive care7 (Table 1).
  Contrary to the inclusion criteria of many NIDCAP studies, we chose the inclusion 
criteria of infants < 32 weeks gestational age because we know from previous 
studies that infants < 32 weeks GA are vulnerable and have an increased risk of 
developmental problems8,9. This was different than other NIDCAP studies previ-
ously published in which the inclusion age was between < 28 and < 30 weeks and 
infants required some form of ventilation in the first 48 hours. Westrup’s study also 
included infants < 32 weeks GA but had some restrictions on respiratory support 
in their inclusion criteria10. We did not make any restrictions concerning ventilation 
because we hypothesized that all infants < 32 weeks GA could benefit from this 
intervention.
  We did not find significant differences in follow-up neurodevelopmental 
outcomes as reported in other NIDCAP studies11-13.  In our study we chose 2 points 
of follow-up at 1 and 2 years corrected age as we wanted to be able to compare our 
results with previous NIDCAP studies. There have been questions raised, however, 
concerning the poor predictive value of the Bayley Scales of Infant Development 
as one large study reported that a subnormal MDI score at 20 months in ELBW 
infants is not predictive of a subnormal cognitive functioning at school age14. This 
could mean that decisions of whether to continue with an intervention in the NICU 
based on 1 and 2 year outcomes may not be appropriate, as effects may not be seen 
until the child is older. 
 To date only the Swedish studies have published developmental outcomes 
beyond 2 years, reporting positive effects on behavior and mother-child interaction 
at 3 years of age from their phase-lag study12 and results at preschool age from 
their RCT which showed no difference in cognition and a possible positive effect 
on behavior in the NIDCAP group. Because the power was low and recruitment 
was half of what they had expected, caution was suggested when interpreting their 
results12,15 (Table 1). It is therefore important that our cohort is followed to at least 
school age to see if there are any effects only evident as the children mature. 
Meta-analysis
 A Cochrane meta-analysis of NIDCAP trials found 3 studies with significantly 
fewer days of ventilation4,10,16, 3 studies with no differences in days of oxygen3,4,13 
and one study with fewer days CPAP and a lower age for oxygen withdrawal10, but 
concluded that results on respiratory support should be viewed with caution due 
to significant heterogeneity among the sites17. It should be noted that they did not 
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include the 3-center trial by Als6 in this meta-analysis because they felt that there 
was too much heterogeneity between the 3 sites. They also reported that NIDCAP 
had a significant effect on moderate-severe chronic lung disease and incidence of 
necrotizing enterocolitis, no effect on length of hospitalization and no effect on 
feeding and growth in infants surviving to 9 months. The effects on neurodevelop-
ment were conflicting with a significant difference in Bayley MDI at 12 months in 
a meta-analysis of 2 trials11,18, but no difference in PDI. They found some positive 
evidence of the long-term effect of NIDCAP at 5 years on behavior and movement 
but no effect on cognition. The authors’ final conclusion was that while there 
was limited benefit of developmental care and no major harmful effects, that the 
outcomes were conflicting and further studies were recommended17. 
Comparison of Phase 1 and 2
 We then looked at the outcomes from both phases 1 and 2 of our study. Even 
though they were 2 separate RCT’s, the level of developmental care given was pro-
gressive in each phase, as we started in phase 1 with a control group with no DC 
and then in phase 2 a control group of basic DC (nests and incubator covers), which 
was comparable to the DC intervention group in phase 1. We hypothesized that if 
the infant characteristics in both phases were comparable, then there would be an 
increasing improvement in outcomes with a more pronounced improvement seen 
between the control group of phase 1 who received no elements of developmental 
care and the intervention group of phase 2 who received the complete NIDCAP inter-
vention. Comparing these 2 groups would be the equivalent of a phase-lag design. 
 However we decided not to perform such an comparison based on the following 
methodological reasons. The first reason was that these were 2 separate RCT’s 
carried out over a period of 4 years in which clinical changes occurred between 
the implementation of the 2 phases. That could mean that the C group in phase 
1 possibly had different medical care approaches than the NIDCAP intervention 
group in phase 2. The second reason was that although various infant characteris-
tics such as birthweight, gestational age, Apgar scores at 5 minutes, CRIB scores and 
inborn at birth were comparable between the C group in phase 1 and the NIDCAP 
group in phase 2, there were some differences in infant characteristics between 
these 2 groups. There were more twins and SGA infants born in the NIDCAP group 
phase 2, and both characteristics can have a negative influence on developmental 
outcome. On the other hand, there were more males born and a higher percent-
age of RDS in the C group of phase 1 than in the NIDCAP group in phase 2 which 
could lead to poorer outcomes in the C group and an advantage for the outcomes 
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in the NIDCAP intervention group. We decided not to correct for these differences 
between the groups with statistical methods and to hold on to the original design 
of the study as 2 separate RCT’s.  
Strengths and limitations of the study
 This was a large randomized controlled trial with a low percentage of lost to 
follow-up. In the phase 1 RCT there could be no blinding of the intervention as the 
developmental care infants had incubator covers and nesting, however it did make 
it possible to ensure a strict control group. The amount of respiratory support given 
to an infant was decided upon by several neonatologists so was not influenced 
by the study group the infant participated in. Discharge from the intensive care 
was based on two criteria: the infant required no mechanical ventilation and/or 
CPAP for 24 hours and weighed at least 1000 grams, so days of IC could also 
not be influenced by group participation. The assessors for both the neurological 
and developmental outcomes were blinded to the treatment group in which the 
children participated. The neurological outcomes were obtained using a standard-
ized neurological examination and the Bayley Developmental Index scores were 
scored using the Dutch norms19. 
Length of the Intervention
 The trial was carried out in a tertiary NICU in two locations. Both locations were 
able to provide intensive care as well as intermediate care, however the length of 
stay in one location was longer as most infants were not transferred to regional 
hospitals but discharged from the NICU nursery to home and only a small per-
centage of the infants in the other location stayed until discharge to home. This 
meant that there was a wide range in length of stay in the participating NICU’s, 
which mainly reflected the period of hospitalization in the intermediate care unit. 
We had hypothesized that an increase in days that infants spent in the two par-
ticipating locations and thereby more days of developmental care would positively 
affect growth and neuromotor outcomes. This however was not the case as was 
shown via an interaction analysis of the intervention duration and the term age 
outcomes.   
 It may be that there were not enough infants who received developmental care 
until discharge to home to show an effect, however we also did not find site differ-
ences in the IC days or days of ventilatory support, which would not be influenced 
by total length of stay. These results were disappointing and we can only conclude 
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that in a subsequent trial the intervention should continue when the infants are 
transferred to regional hospitals. This was beyond the scope of this study as our 
main goal was to look at the effect of developmental care in the Dutch neonatal 
system with centralization of perinatal care.  
 It could also be that an early intervention program provided only in the period 
of hospitalization of the preterm infant is not enough. Perhaps a subsequent study 
should be carried out in which the NIDCAP program is implemented along with 
another program such as the Infant Behavioral and Assessment Intervention 
Program (IBAIP)20. This is an early intervention program based on the NIDCAP 
approach which provides support to parents and their infant up to 6 months 
corrected age. This would be the logical continuation of an approach that would 
help parents in the difficult first months at home with their still fragile infant. It 
would also help to build on the support and knowledge parents received in the 
NICU and guide them in responding to their infant’s quickly changing develop-
mental needs. 
Central Nervous System 
 We found no significant differences in IVH or PVL between the intervention and 
control groups in both RCT’s. It is of course possible that some infants had already 
experienced an IVH prenatally or before entering the study as inclusion was allowed 
up to 48 hours after birth. It was not feasible to include all infants on day one as 
parents needed time to decide whether to participate in the study. It is possible 
that by decreasing the stress and physiological instability the infant experienced 
through providing developmental care may have helped to prevent more cerebral 
damage, but this was not something we were able to measure. A study by Wielenga 
showed a possible decrease in severe cerebral damage in favor of the NIDCAP 
group but stated that the results should be interpreted with caution as it was a 
phase-lag study and there were some differences between the 2 groups21.  Als et 
al have published outcomes on MRI studies showing positive effects of NIDCAP 
on the developing brain, however it was a relatively small number of infants and 
not all infants underwent an MRI at term age13.  It was unfortunately not feasible at 
the time of our study to perform MRI’s at term age, however it is something that 
perhaps could be studied in future trials.
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Practical considerations
 At the onset of our study, little was known about developmental care and imple-
mentation had not yet begun to occur in our NICU’s. This made it easier to have a 
pure control group in Phase 1 with no covers or nesting as that was the standard 
care at that time. As the use of these materials was very visible, it made it easy 
to prevent contamination of the control group. In Phase 2 both groups appeared 
much the same, as both were given basic developmental care which consisted of 
incubator covers and nesting, however the NIDCAP group infants were formally 
observed every 7-10 days and were given individualized developmental care plans 
based on these observations. It is possible to conceive that there was more of a 
chance for contamination as the parents and nurses of the control group infants 
would be able to see some of the interventions being carried out and apply them to 
the infants in the control group. We did feel that since it is an individual approach, 
the argument could be made that what works for one infant may not apply for 
another, however general methods of support during caregiving could conceivably 
be copied. 
 Both intervention and control infants were cared for in the same NICU nursery, 
which can create a greater chance for contamination. However Westrup’s study 
had to be ended before inclusion was completed precisely because the infants were 
cared for in different rooms and it became harder to motivate parents and nurses 
to continue including infants in the control group as the difference in care was 
so obvious10. At the time we did not have the capacity to use two separate rooms 
and it ended up being to our advantage as we were able to include the number of 
infants required by the power analysis. Having all the participating infants in the 
same nursery appeared to actually make it easier for the parents as there was a 
wide variety of infants in the room, including older infants who did not participate 
in the study.
 One way we tried to diminish the effect of contamination was to give extra 
training to the group of nurses who primarily cared for the infants in the NIDCAP 
group. This also permitted more continuation of the care and allowed the nurses 
to become more familiar with the infants’ and parents’ needs. There were only 
5 nurses that underwent the formal NIDCAP training, the rest of the caregiving 
team were given extra instructions in caregiving based on the NIDCAP approach. 
As recommendations have been made to train at least 10% of the staff in order to 
generate a change it is possible that more formally trained nurses are necessary to 
have an effect. 
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Methods of studying developmental care 
 Perhaps a randomized controlled trial is not necessarily the best method to 
measure the effects of a complicated psychological intervention such as the NIDCAP 
program. It is much more difficult to measure than a study of the effect of a new 
medication. In these studies, often double blind, the infant either receives the med-
ication or not with less chance of contamination and outcomes are quantifiable and 
therefore easier to measure. There have been recommendations made for future 
research of developmental care such as randomization by site instead of patients, 
evaluating neurobiological mechanisms or using other approaches to developmen-
tal care research such as qualitative research and continuous quality benchmarking 
as an alternative to RCT’s22.  It has been proposed that these approaches may be 
a more effective way of examining the effects developmental care has on infants 
in the NICU nursery23. However each approach has some methodological restric-
tions. For example, a trial in which sites are randomized instead of patients would 
be difficult to implement as there would be too many differences in medical and 
nursing practices at each site. It may be that a combination of outcomes based 
on various research methods will be needed to produce a body of evidence of the 
effects of developmental care.  
Developmental care research in the Netherlands
 Since we began our study there have been 2 other neonatal centers in the Neth-
erlands carrying out research on NIDCAP developmental care. A phase-lag study 
of 51 infants < 30 weeks was carried out in the AMC/Emma Children’s Hospital in 
Amsterdam in which first a group of 26 infants received conventional care, followed 
by a group of infants who received NIDCAP care. They found a decreased risk for 
more severe cerebral damage in the NIDCAP group after correcting for neonatal 
differences in the groups (birthweight, head circumference, incidence of twins, 
incidence of pneumonia) but did comment that these findings should be inter-
preted with caution21. In addition, parents of the NIDCAP group infants reported 
significantly more satisfaction in caregiving than the parents of the conventional 
care infants24. The neonatal department of the Erasmus-MC Sophia Children’s 
Hospital in Rotterdam is currently carrying out an implementation research trial 
in which the effect of the implementation of the NIDCAP program on staff as well 
as parental stress is being studied. A pilot study carried out to evaluate parental 
stress in the NICU showed the following factors caused stress in parents: health 
status of the infant, parental role alteration, staff behaviors and communication 
and equipment and sound 25. They are now in the process of completing their study 
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of providing NIDCAP for infants born ≤ 30 weeks. Once all results are published, 
we will be able to have a clearer view of the effect of implementing NIDCAP in the 
Dutch neonatal system.
Parents
 One of the effects of the NIDCAP intervention was that fathers were encour-
aged to participate in the caregiving of their infant. This was a recommendation 
we made after our pilot study findings because fathers stated that they wanted to 
become more involved in their child’s care and acquire more knowledge of preterm 
infant behavior26. We found that fathers of infants in the NIDCAP group exhibited 
more stress than fathers of infants in the control group and concluded that this 
was perhaps because they were more involved in their child’s care, so would not be 
able to maintain the emotional distance that they would have if not so involved in 
the caregiving27. It is therefore important to not only find ways of including fathers 
in the caregiving in future programs but find ways of providing them with support. 
 Both parents and the nursing team were positive about NIDCAP and the nurses 
expressed an interest in receiving more developmental care in-services and bedside 
support28. This finding has been reported in previous trials as well as our study24,29. 
As NIDCAP is a humane way of caring for infants and does no harm30, it is  important 
that the wishes of parents and nurses should also be taken into consideration when 
deciding whether to implement this approach to caregiving. In a study of  mothers 
of infants in the NIDCAP group, the mothers perceived more closeness to their 
infants at 36 weeks post menstrual age (PMA) than did the control mothers and 
rated the staff’s ability to support them in their role as a mother somewhat higher. 
They also expressed more anxiety than did the control group mothers which was 
similar to our findings of fathers of the NIDCAP infants. Kleberg suggests that 
the reason may be that the mothers in the NIDCAP group had already bonded to 
their infants during the hospital stay31. We felt also that perhaps fathers were more 
involved in their infant’s care and this raised their level of stress. 
Developmental care in NICU’s in the Netherlands 
 There has been an increasing centralization of perinatal care in the Netherlands, 
with a twofold increase in the number of very preterm infants being born in tertiary 
centers9,32,33. Infants are often transferred from the neonatal centers to regional 
hospitals with intermediate care once stable enough to be discharged from the 
General Discussion
119
intensive care. This policy is used in order to ensure sufficient intensive care beds 
are available for new admissions but may also impact any programs implemented 
in the NICU, as infants may be transferred out within weeks after birth. Because 
this may directly affect outcomes of these early intervention programs in the NICU, 
the importance of a continuation of such programs once the infant is transferred to 
a regional hospital should be emphasized. 
Conclusions
 Based on our findings the following conclusions can be made concerning the 
implementation of developmental care and with emphasis on the NIDCAP devel-
opmental care program.
 Basic developmental care has a positive effect on psychomotor development at 
1 year of age in children born < 32 weeks. Since it is fairly inexpensive and not time 
consuming to implement, NICU nurseries should at least implement basic devel-
opmental care.
 It is possible that the NIDCAP intervention was not provided long enough to be 
able to make any final conclusions concerning outcome effects. A subsequent study 
is needed involving not only the neonatal centers but also the regional hospitals 
with intermediate care since infants may be transferred to them within weeks after 
birth. 
 In addition, early intervention programs provided only in the period of hospital-
ization of the preterm infant are possibly not enough to produce results and that 
a subsequent study should be carried out in which the NIDCAP program is imple-
mented along with a home-based intervention for parents and infants when they 
are discharged from the hospital. 
 We have examined the effects of developmental care in the NICU in the Dutch 
neonatal system of centralized perinatal care and hope that we have been able to 
answer some of the questions posed back when developmental care was first intro-
duced in the Netherlands. However we feel that more research is warranted before 
a definite conclusion can be made concerning the effect of developmental care on 
preterm infants and families.
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Recommendations for future research
Based on our conclusions, recommendations for further studies are: 
1. A follow-up study at school age of the infants from our 2 RCT’s to see if there 
are any later effects of the intervention and ideally continuing to follow these 
children as they mature; as this is a large cohort, they may reveal answers to 
long term effects of prematurity.
2. Examine the effect of developmental care provided not only in the neonatal 
centers but also in the regional hospitals in order to see if a longer intervention 
has an effect on outcomes.
3. Initiate a phase 3 study in which the NIDCAP intervention in the neonatal nursery 
is combined with an intervention program once infants are discharged to home 
to see if this continuing support of infants and families will show improved 
outcomes.
4. Measure the effect of developmental care on younger, sicker preterm infants 
such as ventilated infants born < 30 weeks GA to compare results with previous 
NIDCAP studies and to see if the effect is greater.
5. A developmental care study in which the biological effect on the brain such as 
in MRI studies or other quantifiable biological stress measurements are used to 
measure outcomes.
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Summary
This thesis examines the effect of a developmental care program in a tertiary NICU 
in 2 locations in the Netherlands on preterm infants born < 32 weeks gestational 
age. 
Chapter 1. Introduction
 Chapter 1 describes the incidence of preterm birth and risks associated with 
prematurity as well as the impact of the NICU on the infant and family. Research 
on the sensory development of the preterm infant have shown that many of the 
environmental factors and care practices in the NICU have a significant impact on 
infant sensory development. Developmental care programs have been developed 
to support the infant and family during their stay in the Neonatal Intensive Care 
Unit (NICU) with the premise that reducing the stress the infant experiences in 
the NICU and supporting the infant’s development may have a positive impact on 
outcomes. The NIDCAP (Newborn Individualized Developmental Care and Assess-
ment Program) is a comprehensive approach in which caregiving is based on the 
individual behavior of the infant.  Developmental care is a fairly new concept in the 
Netherlands with little known about its effect in the neonatal system in the Nether-
lands where there is a centralization of perinatal care. To that aim, we carried out 2 
consecutive randomized controlled trials to examine the effect of a basic develop-
ment care program and the comprehensive NIDCAP program on short and long 
term growth, morbidity and neurodevelopment of preterm infants born < 32 weeks 
gestational age. 
 
Chapter 2. Hospital based intervention with parents and their preterm infants
 Chapter 2 describes a short-term, hospital based intervention study with 10 sets 
of parents and their preterm infants < 32 weeks in the NICU. This was a phase-lag 
pilot study in which parents in the intervention group were instructed in preterm 
infant behavior with the goal of increasing their responsiveness to their infant and 
therefore their confidence in caregiving. While the lessons significantly increased 
their knowledge of premature infant behavior, their level of confidence in caregiving 
increased but not significantly. Parents in the control group who did not receive the 
instructions showed no increase in confidence in caregiving. While no large effect 
was found, it did indicate that it is feasible to start an intervention program with 
parents early on in the NICU period. We concluded that a longer, more intensive 
program with a larger sample size was necessary. 
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Chapter 3. Short-term effects of Basic Developmental Care
 In Chapter 3 we examined the effects of basic developmental care (DC), which 
we de-fined as the use of incubator covers and positioning aids, on short term 
morbidity, growth and neurodevelopmental outcomes to term age in preterm 
infants born < 32 weeks gestational age. 192 infants were recruited and a total of 
179 infants (DC=91, C=88) met inclusion criteria. In-hospital mortality was 12/91 
(13.2%) in the DC group and 8/88 (9.1%) in the C group. Ten (DC=3, C=7) infants 
were lost to follow-up. There was no significant difference in the number of days of 
respiratory support, number of intensive care days, short-term growth or neuromo-
tor developmental outcome at term age between the DC and C groups. Duration 
of the intervention, whether only during the intensive care period or until hospital 
discharge, had no significant effect on outcome. We concluded that providing basic 
developmental care in the NICU has no effect on short-term physical and neuro-
logical outcomes in infants born < 32 weeks GA.
Chapter 4. Effect of Basic Developmental Care on 1 and 2 year outcomes
 In Chapter 4 we report the effect of basic developmental care on growth and neu-
rodevelopmental outcome at 1 and 2 years CA of preterm infants < 32 weeks. 
Of the 159 surviving infants, 147 children (DC= 74, C= 73) at 1 year and 142 children 
(DC=72, C=70) at 2 years were assessed. No significant difference in growth, neu-
rological outcomes or MDI was found. A positive trend in PDI at 1 year (p=0.05) 
did not continue once the children reached 2 years of age. When neurological 
and developmental scores were combined, the C group showed more “definitely 
abnormal” scores than the DC group at both ages, but this did not reach the level 
of significance. We concluded that basic developmental care has a positive effect 
on psychomotor development at 1 CA, but no effect on neurological and mental 
development or growth at 1 and 2 years CA. 
Chapter 5. Short-term effects of NIDCAP Developmental Care
 Chapter 5 describes the effect of the comprehensive NIDCAP developmental care 
program in preterm infants < 32 weeks GA on short term morbidity, growth and neu-
rodevelopmental outcomes to term age. 168 infants were recruited (NIDCAP=84; 
C=84). Four infants (NIDCAP=3, C=1) were excluded because they were admitted 
less than or died within the first 5 days, leaving a total of 164 infants (NIDCAP=81, 
C=83) that met inclusion criteria. In-hospital mortality was 8/81 (9.9%) in the 
NIDCAP group and 3/83 (3.6%) in the C group. No difference in mean days respi-
ratory support (13.9/16.3) or mean days IC (15.2/17.0) were found (NIDCAP/C, 
respectively). Short-term growth and neuromotor development at term age showed 
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no differences, even when correcting for the duration of the intervention. Our con-
clusion was that NIDCAP developmental care has no effect on respiratory support, 
intensive care days or growth and neuromotor development at term age. 
Chapter 6. Effect of NIDCAP on 1 and 2 year outcomes
 Chapter 6 examined the effect of NIDCAP in preterm infants < 32 weeks GA on 1 
and 2 year growth and neurodevelopmental outcomes. Of the 153 surviving infants, 
148 children (NIDCAP= 70, C= 78) at 1 year and 146 children (NIDCAP=68, C=78) at 
2 years were assessed. There was no significant difference in growth, neurological 
outcome or mental and psychomotor development at 1 and 2 years found. When 
neurological outcome, MDI and PDI scores were combined, there still remained 
no significant difference. We concluded that NIDCAP developmental care showed 
no effect on growth, neurological, mental and psychomotor development at 1 and 
2 years in infants born < 32 weeks. Duration of the  NIDCAP intervention was not 
associated with neurological and developmental outcome. 
Chapter 7. General Discussion 
 Chapter 7 contains the General Discussion of the results of this study. We 
examined the methodology of our RCT’s and compared our results to previous 
NIDCAP trials. We suggested that more research is warranted before a definite 
conclusion can be made concerning the effect of developmental care on preterm 
infants and families. A recommendation for future research was studying the effect 
of developmental care not only in the neonatal centers but also continuing the 
intervention once infants are transferred to regional hospitals. There may also be 
an added effect to providing early intervention for parents and infants in the first 
months after discharge to home and therefore such programs should be evaluated 
in future trials.
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Samenvatting
Dit proefschrift geeft de resultaten weer van het onderzoek naar het effect van 
ontwikkelingsgerichte zorg in een tertiaire Neonatale Intensive Care Unit (NICU) 
op 2 locaties in Nederland bij kinderen geboren na een zwangerschapsduur van 
minder dan 32 weken.
Hoofdstuk 1. Algemene Inleiding
 Hoofdstuk 1 beschrijft de incidentie van vroeggeboorte en de daarmee verbonden 
risico’s, alsmede het effect van de NICU omgeving op het kind en de familie. 
Onderzoek naar ontwikkeling van de te vroeg geborene heeft laten zien dat veel van 
de omgevingsfactoren en handelingen in de NICU effect hebben op de sensorische 
(zintuiglijke) ontwikkeling van het kind. Ontwikkelingsgerichte zorg programma’s 
zijn ontwikkeld om het kind en het gezin te ondersteunen tijdens de opname in de 
NICU. Verondersteld wordt dat vermindering van de stress en ondersteuning van de 
ontwikkeling van het kind een positief effect kan hebben op de latere ontwikkeling.
 Het Newborn Individualized Developmental Care and Assessment Program 
(NIDCAP) is een uitgebreide benadering waarin de zorg is gebaseerd op het indi-
viduele gedrag van het kind. Ontwikkelingsgerichte zorg is een betrekkelijk nieuw 
begrip in Nederland en er is weinig bekend van het effect op vroeggeborenen in 
Nederland. Wij hebben twee opvolgende gerandomiseerde onderzoeken gedaan 
naar het effect van basiselementen van  Ontwikkelingsgerichte Zorg en het volledige 
NIDCAP programma. Korte termijn uitkomsten behelsden de neonatale morbidi-
teit en groei en de neuromotorische ontwikkeling op à terme leeftijd. Op de leeftijd 
van 1 en 2 jaar gecorrigeerd voor vroeggeboorte werden de neuromotorische ont-
wikkeling en de psychomotorische en mentale ontwikkeling van kinderen geboren 
< 32 weken zwangerschapsduur onderzocht.
Hoofdstuk 2. Pilot studie met ouders en hun te vroeg geboren kind
 Hoofdstuk 2 behandelt een pilot studie in de NICU bij 10 ouderparen en hun 
kinderen geboren voor een zwangerschapsduur van 32 weken. Dit was een phase-
lag studie waarbij ouders in de interventie groep les kregen in het gedrag van te 
vroeggeborenen met het doel om het zelfvertrouwen in de zorg van hun kind te ver-
beteren. Hoewel de lessen de kennis van de ouders over het gedrag van premature 
kinderen significant verbeterden, was hun zelfvertrouwen, hoewel groter, niet signi-
ficant gegroeid. Bij de ouders in de controle groep die geen lessen kregen zagen we 
geen toename in het zelfvertrouwen. Hoewel er geen groot effect werd gevonden, 
liet deze pilot studie wel zien dat een interventieprogramma met ouders al vroeg 
in de NICU periode mogelijk is. Wij concludeerden dat een langere en intensievere 
interventie met een grotere populatie noodzakelijk was.
Hoofdstuk 3 Korte termijn effecten van basis Ontwikkelingsgerichte Zorg
 Hoofdstuk 3 geeft het onderzoek weer naar de effecten van basis Ontwikkelings-
gerichte Zorg (couveusehoezen, nestjes en ondersteunende hulpmiddelen) op 
morbiditeit, groei en neuromotorische ontwikkeling tot op de à terme leeftijd in 
kinderen < 32 weken zwangerschapsduur. Er werden 192 kinderen in het onderzoek 
opgenomen en 179 kinderen (DC=91, C=88) konden geïncludeerd worden. Er 
overleden 12/91 (13,2%) kinderen in de DC groep en 8/88 (9,1%) in de C groep 
tijdens de ziekenhuisopname.
 Tien (DC=3, C=7) kinderen waren niet beschikbaar voor follow-up. Er werd geen 
significant verschil in het aantal dagen beademing, het aantal intensive care dagen, 
de groei vanaf geboorte tot aan à terme leeftijd en de neuromotorische ontwik-
keling op à terme leeftijd, tussen de DC en C groepen gevonden. De duur van de 
interventie had geen effect op de uitkomsten. 
 Onze conclusie was dat basis Ontwikkelingsgerichte Zorg in de NICU geen effect 
heeft op de korte termijn morbiditeit, de groei en neuromotorische uitkomsten bij 
kinderen < 32 zwangerschapsweken.
Hoofdstuk 4. Effect van basis Ontwikkelingsgerichte Zorg op 1 and 2 jaar
 In hoofdstuk 4 keken we naar het effect van basis Ontwikkelingsgerichte Zorg 
op groei, neuromotorische ontwikkeling en de mentale en psychomotorische ont-
wikkeling op 1 en 2 jaar gecorrigeerde leeftijd van kinderen < 32 weken. Van de 
152 kinderen die overleefden werden 147 kinderen (DC=74, C=73) op 1 jaar en 142 
kinderen (DC=72, C=70) op 2 jaar onderzocht. Er werd geen significant verschil 
in groei, neurologische uitkomsten en in de Mental Developmental Index (MDI) 
gevonden. Wel werd een positieve trend van de Psychomotor Developmental Index 
(PDI) op 1 jaar (p=0.05) vastgesteld, maar er was geen verschil meer te zien op 
2 jaar. Na combinatie van de neuromotorische MDI en PDI scores tot één uit-
komstvariabele, had de C groep meer “sterk abnormale” scores dan de DC groep 
op beide leeftijden, echter het verschil was niet significant. Wij concludeerden dat 
basis Ontwikkelingsgerichte Zorg een positief effect heeft op de psychomotorische 
ontwikkeling op de gecorrigeerde leeftijd van 1 jaar, maar geen effect op de neuro-
motorische en mentale ontwikkeling op de gecorrigeerde leeftijd van 1 en 2 jaar.
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Hoofdstuk 5. Korte termijn effecten van NIDCAP ontwikkelingsgerichte zorg
 Hoofdstuk 5 beschrijft het effect van het volledig NIDCAP programma voor pre-
maturen < 32 weken op de korte termijn morbiditeit, groei en de neuromotori-
sche ontwikkeling  tot de à terme leeftijd. Er werden 168 kinderen in het onderzoek 
opgenomen (NIDCAP=84, C=84). Vier kinderen (NIDCAP=3, C=1) werden geëx-
cludeerd omdat ze minder dan vijf dagen waren opgenomen, of stierven binnen 
de eerste vijf dagen, zodat er een totaal van 164 (NIDCAP=81, C=83) kinderen 
overbleef. Er overleden 8/81 (9.9%) kinderen in de NIDCAP groep en 3/83 (3.6%) 
in the C groep tijdens de ziekenhuisopname. 
 Er was geen significant verschil in het aantal dagen beademing of intensive care. 
Er was ook geen verschil in korte termijn groei en neuromotorische ontwikkeling 
op à terme leeftijd, zelfs wanneer er gecorrigeerd werd voor interventieduur. Onze 
conclusie was dat NIDCAP geen effect heeft op beademings- en IC dagen, of op 
korte termijn morbiditeit en neuromotorische ontwikkeling. 
Hoofdstuk 6. Het effect van NIDCAP op 1 en 2 jaar
 In Hoofdstuk 6 worden de resultaten vermeld van het effect van NIDCAP op de 
gecorrigeerde leeftijd van 1 en 2  jaar bij kinderen  geboren < 32 weken, op de groei, 
neuromotorische ontwikkeling en de mentale en psychomotorische ontwikkeling. 
Van de 153 overlevende kinderen werden 148 kinderen (NIDCAP=70, C=78) op 1 jaar 
en 146 kinderen (NIDCAP=68, C=78) op 2 jaar onderzocht. Er werd geen significant 
verschil in groei, neurologische uitkomsten of mentale en psychomotorische ont-
wikkeling op 1 en 2 jaar gevonden. Na combinatie van de neurologische uitkomsten, 
MDI en PDI scores tot één variabele, bleek er eveneens geen significant verschil 
tussen de groepen te zijn. De duur van de NIDCAP interventie had geen effect 
op de neurologische en ontwikkelingsuitkomsten. Wij concludeerden dat NIDCAP 
ontwikkelingsgerichte zorg geen effect op groei, neuromotorische, mentale en psy-
chomotorische ontwikkeling op 1 en 2 jaar heeft bij kinderen geboren na een zwan-
gerschapsduur van minder dan 32 weken. 
Hoofdstuk 7. Algemene discussie
 Hoofdstuk 7 bevat de algemene discussie van de resultaten van dit onderzoek. 
Wij onderzochten de methodologie van onze RCT’s en vergeleken onze resultaten 
met eerdere NIDCAP trials. Wij menen dat meer onderzoek nodig is voordat een 
definitieve conclusie kan worden getrokken over het effect van ontwikkelingsgerichte 
zorg op premature kinderen en hun families. Aanbevelingen voor toekomstige trials 
zijn het onderzoeken van het effect van NIDCAP niet alleen in de neonatale centra 
maar ook wanneer de kinderen worden overgeplaatst naar perifere ziekenhuizen. 
Het zou misschien ook van toegevoegde waarde kunnen zijn een interventiepro-
gramma voor ouders en kinderen in de eerste maanden na ontslag uit het zieken-
huis te combineren met de NIDCAP interventie  tijdens de opname. De effecten 
van dergelijke programma’s dienen in toekomstige trials te worden onderzocht.
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List of Abbreviations
ADHD attention deficit hyperactivity disorder
BPD bronchopulmonary dysplasia
BSID-II Bayley Scales of Infant Development II
C control
CA corrected age
CPAP continuous positive airway pressure
CRIB Clinical Risk Index for Babies
CSF cerebrospinal fluid
DA definitely abnormal
DC developmental care
E experimental group
GA gestational age
GC Global Confidence 
HELLP hemolysis, elevated liver enzymes, and low platelet count
HFO high frequency oscillation
IVH intraventricular hemorrhage
LCC Lack of Confidence in Caregiving 
LOS Length of stay
MA mildly abnormal
MABS Mother and Baby scale 
MDI mental developmental index 
N normal
NEC necrotizing enterocolitis
NICU Neonatal Intensive Care Unit
NIDCAP Newborn Individualized Developmental Care and Assessment Program
OFC occipital-frontal circumference
P percentile
PCA postconceptional age
PDA patent ductus arteriousus
PDI psychomotor developmental index 
PROM premature rupture of membrane
PVL periventricular leukomalacia
RCT randomized controlled trial
RDS respiratory distress syndrome
ROP retinopathy of prematurity
SDS standard deviation scores
SGA small for gestational age
SIMV synchronized intermittent mandatory ventilation
VLBW very low birth weight
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